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ABSTRACT
The thymus is known to play a vital part in the 
development and maintenance of the immune system. This 
study investigated the effects of the compound, Di-n-octyl- 
tin dichloride COOTC] , upon the thymus and the consequences 
of the DOTC-induced thymic injury upon immunocompetence.
Oral exposure of PVG rats to DOTC produced a marked 
loss of thymic weight observed 4 days after commencement 
of treatment. The toxic effects of DOTC were observed 
to be primarily restricted to the thymus, however, a 
gradual decrease in the numbers of lymphocytes in the blood 
was observed subsequent to DOTC induced thymic weight loss.
Insight into the mode of action of DOTC upon the thymus 
was obtained by investigating some factors which might have 
influenced the extent and reversibility of DOTC-induced 
thymic injury. Age appeared to have a considerable effect 
upon.DOTC-induced thymic injury and reversibility, whereas 
adrenalectomy prior to treatment did not alter the extent 
or nature of thymic damage.
Investigations into the consequences of DOTC-induced 
thymic injury upon the immune system demonstrated a 
decrease in polyclonal T-cell activation as measured by 
mitogenic blastogenic responsiveness and in allogeneic 
reactivity as measured by the mixed lymphocyte response. 
There was no significant alteration in T-cell dependent 
antibody production to a systemically administered antigen. 
The effects upon the immune system appeared to be limited 
in both extent and degree and were more comparable to
those generally observed after adult thymectomy than 
those documented after administration of immunosuppressive 
drugs.
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CHAPTER ONE
INTRODUCTION
1.1 GENERAL INTRODUCTION
The growth of immunology as a science in recent years has
led to an increasing awareness that compounds undergoing toxi-
cological evaluation should be tested for possible effects upon
the immune system. An increasing number of reports are being
published about compounds which affect the immune system CVos,
1 977; Dean et al., 1979; Faith et al., 1980; Sharma, 19813- The
consequences of damage to the immune system to the affected
individual s t ill remain to be fully quantified and understood
in many cases, particularly with reference to the immunocompom- 
♦
petent state of that individual. The thymus can also be 
affected before other organs, making i t  a sensitive indicator 
of organ toxicity CMiller, 1983].
1.2 THYMIC STRUCTURE AND DEVELOPMENT
The thymus is a bilobed organ found in the upper thorax 
of most vertebrates. In mammals the normal adult thymus is 
divided into an outer cortex and an inner medulla. The thymus 
consists of a network of reticular epithelial cells CREC] 
populated by a large number of small cells with dense nuclei, dj 
hicfi nuclear to cytoplasm ratio, of lymphoid origin called 
thymocytes. The thymocytes are seen to undergo many cell 
divisions [mitotic figures are common]. The thymocytes are 
thought to be developing into immunocompetent T lymphocytes.
The cortex is usually more densely populated with thymocytes 
than the medulla. The epithelial cells are characterised
at the electron microscope level by demosomes and tonoFibrils.
Some myeloid epithelial cells, containing bundles of myeloid
Fibrils are present. Macrophages are also present but in
small numbers in the undamaged thymus. In species other than
rats, Hassail*s corpuscles are Frequently seen Cthey are
rare in the rat]. Hassall’s corpuscles are whorls oF Flattened
epithelial cells. The thymocytes in the medulla have a
oF cells
greater proportion^bearing the surFace antigens which are 
similar to those present upon mature lymphocytes. Most thymo­
cytes in the cortex have a surFace antigenic determinant which 
is typical oF immature lymphocytes CCantor et _al., 1978;
Rouse S Weissman, 1981],
The thymus is derived From the third and Fourth pharyngeal 
pouches during ontogeny. I t  is recognisable as a distinct 
entity as early as the twelFth day oF gestation in mice, when 
cells morphologically recognisable as lymphocytes are seen 
in the thymic rudiment CMandel, 1970]. Cells morphologically 
recognisable as thymocytes are seen in the human embryonic 
thymus between the 7th and 9th week oF gestation [Janossy et 
al., 1981], In mice,the commencement oF lymphoid cell
mitotic activity coincides temporally with the diFFerentiation 
oF the REC. Thus the cortical REC appear to play a major role 
in thymic development. I t  is known that REC produce humoral 
Factors or hormones which are necessary For thymocyte 
maturation [Trainin et ail., 1983], Cell-cell interactions are 
also important between REC and thymocytes For the production 
oF mature T lymphocytes CStutman, 1978].
In humans the thymus attains greatest weight relative to 
body weight at birth, greatest absolute weight at puberty,
after which i t  declines in terms of both absolute and 
relative weight. There is a similar growth pattern in 
rodents CVos, 1977].
1.3 LYMPHOCYTE FUNCTIONS
The lymphocytes found in the periphery Ci.e. blood, 
spleen and lymph nodes] in mice, rats and man have been 
divided into two subclasses, B and T lymphocytes,on grounds 
of function and surface antigenic determinants. The B 
lymphocytes are responsible for the synthesis of antibody, 
and are recognized by the presence of antibody or immuno­
globulin on their surface. T lymphocytes express surface 
antigenic determinants specific for T cells and require the 
presence of the thymus anc/or thymic humoral factors for 
immunocompetent maturation. T lymphocytes can be further 
subdivided into subgroups of regulatory [both helper and 
suppressor], cytotoxic and effector cells. The immune 
reactions mediated by T cells include the control of pro­
duction of T-dependent antibody via positive or helper 
cell regulation, recognition and reactions against allo- 
antigens, defence against bacterial, fungal and viral 
infections and regulation of the immune response via 
so-called suppressor factors.
1.4 SIGNIFICANCE OF ATHYMIA OR THYMECTOMY
Studies on thymectomised animals may be criticised 
as inconclusive in that thymic function may have been 
operative in the later steps of foetal development. These 
difficulties can be overcome by the use of congenitally
athymic rodents. Hairless or nude mice were First 
reported in 1966 CFlanagan, 1966] but i t  was not until 
1968 that i t  was reported that these mice lacked a thymus 
CPanteloruis, 1968]. Nude mice are prone to infections 
and wasting disease or runting syndrome. Similarly they 
are unable to produce antibodies in response to challenge 
with T dependent antigens and have an impaired allogenedc 
response. They are able to mount a limited, delayed 
allogeneic response to skin grafts but this is thought to 
be mediated by complement and natural killer cells 
rather than by T cell cytotoxicity. Natural killer cells 
are of lymphoid lineage with non-specific cytotoxic 
activity and are present in greater than normal numbers in 
nude mice.
*
Nude mice also have an enhanced ability to produce 
antibodies in response to challenge with some T-independent 
antigens, perhaps due to lack of suppressor T cells 
[Kindred, 1981],
Nude rats have also been described, they were firs t 
noted at the Rowett Institute in 1953, but died out.
However, they reappeared in 1975 at LAC, Carshalton and in 
New Zealand.
These rats show similar immune defects to the nude mice 
but to a lesser degree. They are less prone to wasting 
disease and infections than nude mice [Festing, 1981].
Neonatally thymectomised mice and rats are unable to 
produce antibodies in response to challenge with T-dependent 
antigens such as Sheep Red Blood Cells [SRBC], tetanus 
toxoid, Bovine Serum Albumen [BSA] or Salmonella typhii.
These rodents also show a distinctly impaired ability to 
reject allogeneic and xenogeneic skin grafts. Lymphocytes 
from such animals when grafted into suitable histoincom- 
patible hosts are impaired in their ability to mount a 
Graft versus Host [GvH] reaction. The secondary lymphoid 
organs of such rodents are reduced in size with decreased 
follicular organisation and cellularity,and germinal centres 
are absent. There is also an increased susceptibility to
infections and i f  they are not maintained in germ-free
they
environments frequently suffer from a fatal runting syndrome, 
A
and an increased susceptibility to infections [Miller, 19G2; 
Miller, 1961; Good _et al. , 1962; Jankovic, 1962],
Thymectomy of the adult rodent has a much less severe 
effect upon the immune system CBach et a l., 1971; Miller,
1962; Jeejeebhoy, 1965]. After 5-7 months post thymectomy, 
adult mice exhibit a decreased ability to respond to newly 
presented antigens which is greater than the normal age 
dependent decline in immunocompetence. The number of 
leucocytes in the peripheral blood is also reduced. The 
decline in immunocompetence can be assessed by the ability 
to produce antibodies in response to T-dependent antigens, 
the ability to mount a GvH reaction or the proliferation of 
lymphocytes in vitro after stimulation with plant lectins or 
mitogens such as phytohaemagglutinin [PHA] or concanavalin A 
CCON A] [Miller, 1962, 1965; Metcalf, 1965; Taylor, 1965; 
□oenhoff et al., 1979]. The longevity of adult-thymectomised 
rodents is also decreased [Jeejeebhoy, 1971]. The most 
striking effect of adult-thymectomy is the greatly impaired 
ability to recover from irradiation [Miller, 1962] or
antilymphocyte therapy [Jeejeebhoy, 1965]. There is also 
evidence that suppressor cells, which normally control the 
production of autoantibodies,are inactivated leading to an 
increased incidence of autoimmune diseases [Borel erfc ail. ,
1980; Weetman jet 1^^ ., 1982; Ahmed S Penhale, 1981], Thus i t  
would appear that a major role of the thymus is the 
maturation and maintenance of the immunocompetent T cells.
In the adults there is normally only a small requirement for 
replacement immunocompetent T lymphocytes but immunological 
trauma such as exposure to radiation or infections could 
create a larger demand.
Immunocompetence in nude and neonatally thymectomised 
rodents has been restored by thymus or thymus tissue 
transplantation within millipore chambers [Osaba S Miller,
1963]. I t  has further been demonstrated that the thymus 
produces a number of thymic hormones which,on administration 
to animals suffering from a maturational defect in T 
lymphocytes,will alleviate the symptoms [Trainin S Zipri,
1975; Lepault est al. , 1979], However, there is some evidence 
that the thymic microenvironment and cell-cell contact between 
REC and thymocytes is necessary for some steps in thymic 
maturation [Stutman, 1978].
1.5 ENDOCRINE INTERACTIONS
Sexual maturation has been found to be impaired in nude 
and neonatally thymectomised rodents [Nishizuka S Sakakura,1979; 
Pierpaoli 6 Sorkin, 1 972 ; Deschaux aJL j 1 979] which indicates that 
there is a thymic influence on the endocrine system. I t  is also 
well-known that there are endocrine influences on the thymus,
gonadectomy of either sex producing thymic hypertrophy 
[Nelson et al., 1967; Sobhon S Jirassaltham, 1974; Castro, 
1976]. Ovariectomy results in thymic hypertrophy which is 
potentiated by adrenalectomy, reversed by administration of 
progesterone and oestrogen and also produces a raised 
leucocyte count in blood [Sobhon S Jirassaltham, 1974]. 
Pregnancy causes a reversible thymic atrophy in mice which 
presents itself histopathologically as atrophy of the 
medullary area of the thymus and immunologically as a 
depressed maternal immunocompetence [Nelson et al., 1967;
Gambei et al., 1980], Orchidectomy also produces thymic 
hypertrophy which is reversed by testosterone administration 
[Castro, 1976]. Testosterone administration produces thymic 
atrophy in intact and gonadectomised animals of either sex. 
Thymic atrophy can be induced in adrenalectomised rats by 
testosterone demonstrating its independence of the adrenal 
cortex [Sasson S Mayer, 1980], Orchidectomy leads to a 
delay in the onset of thymic involution [Castro, 197'6].
Histopathologically orchidectomy produces a widening 
of the cortex and medulla, whereas testosterone causes a 
decrease in cortical cellularity and is thought to act via 
the REC [Sasson S Mayer, 1981]. Orchidectomy produces a 
potentiation of cellular immune responses as measured by 
rejection of allografts, GvH response, delayed hyper­
sensitivity and production of T—dependent antibodies but 
T-independent humoral immune functions are unaltered 
[Castro, 1976].
As an experimental model, male rodents are preferable 
to female as they have less cyclical hormonal fluctuations
to complicate the interpretation of results. Male rodents 
and men have been demonstrated to have a lower response than 
females to cell-mediated immune function tests such as 
T-dependent antibody production and lymphocyte proliferation 
in response to mitogens [Washburn,Mediaris S Childs, 1965; 
Terres et al_. , 1968; Eidenger S Garett, 1972; Kongshavn S
Bliss, 1970] . Thus males are considered a more useful model 
for the chemically induced effects upon immune function.
Adrenocortico-steroids cause rapid [within hours] 
thymocytolysis in the cortical area of the thymus, but the 
mature thymocytes in the medullary area of the thymus are 
more resistant, only being affected by high doses. No 
degenerative changes in the REC are seen with modest doses 
of corticosteroids but there are some at high doses [Lundin
i
S 5chelin, 1969]. The thymocytolysis gives rise to an 
infiltration of macrophages and other phagocytic cells into 
the thymic cortex [Claeson S Ropke, 1969; Ficek, 1980], 
[Progesterone at low doses can act as a glucocorticoid 
antagonist [Duncan S Duncan, 1978].] When investigating 
thymic atrophy i t  is possible to discriminate between direct 
effects on the thymus and indirect effects mediated by 
glucocorticoids by performing experiments on adrenalecto- 
mised animals.
1.6 INFLUENCE OF AGE ON THE IMMUNE 5YSTEM
There is an age-dependent decline in immunocompetence 
which is associated with thymic involution [Piantanelli et al. 
1980; Goidl et a l., 1976; Hal1green et a l., 1973; Gerber
et al., 1974]. This decline in immunocompetence can be
reversed by grafting young thymuses into old rats, the degree 
of immunopotentiation being dependent on the age of the 
grafted thymus [Yunis et al. , 1972; Hirokawa, 1977].
Histopathologically,in the involuting thymus there is a 
preferential loss of cortical thymocytes with degenerative 
changes in the REC [Hirokawa, 1977; Bartel, 1979]. This is 
an indication that there is a requirement for active REC to 
maintain full immunocompetence. The question is whether the 
actively developing thymus with excess replacement potential 
is more at risk than the degenerating thymus which is perhaps 
already unable to cope with any requiements for fresh 
thymocyte maturation. The evidence points to the thymus as 
being the limiting factor in the age-dependent decline in 
immunocompetence [Hirokawa et si., 1982; Webster et a l., 1978]
rather than the supply of immature nonimmunocompetent 
thymocytes. Thus anything which damages the maturational 
abilities of the thymus would be expected to enhance the 
age-dependent decline in thymic functions. The young rodent 
thymus has maturational capabilities which are absent in 
older animals [Hirokawa et al. , 1982; Yunis et al. , 1972],
1.7 IMMUNOSUPPRESSIVE DRUGS
Many compounds have been used therapeutically to depress 
the immune system in conditions thought to be partly or 
wholly mediated by the immune system, e.g. Systemic Lupus 
Erythematasus [SLE] graft rejection in kidney transplants, 
etc., thyroiditis and other autoimmune diseases. The effects 
of glucocorticoids have been covered briefly in the preceding 
section [1.6]. The majority of nonglucocorticoid immuno­
suppressive drugs produce a non-selective effect upon the 
immune system by acting on rapidly developing cells such 
as lymphocytes and haematopoietic cells. There are two 
main types a] alkylating agents such as cyclophosphamide 
and b] antimetabolites such as Methotrexate* Cyclophos­
phamide acts on of guanine residues in ONA and interferes 
with nucleic acid synthesis blocking the cell cycle in the 
phase. The antimetabolites usually act via their 
structural analogy with nucleic acid bases, or inhibit 
essential enzymes necessary for dte novo synthesis of nucleic 
acid bases, thus stopping the cell in the S phase of the 
cell cycle. Both types of compound act non-selectively 
on rapidly dividing cells and their effects are reversible 
on cessation of treatment. Due to the non-selective nature 
of their mode of action, both T and B cell immune functions 
are affected. CX and gamma irradiation probably act via the 
same type of non-selective antiproliferative action [Brent 
S Medawar, 1966].]
1.8 COMPOUNDS AFFECTING THE IMMUNE SYSTEM
Many chemicals of environmental concern have been 
demonstrated to affect the immune system. There are several 
reviews on the topic [Vos, 1977; Faith et al., 1980; Dean
et al., 1979] i n experimental animals.
Some chemicals affect the immune system indirectly.
2[[methy-sulfinyl j^acetyl]pyridine [Oxisuran] acts via the 
adrenal cortex as its effects are absent in adrenalecto- 
mised animals [van Dijk, 1979]. Arachidonic acid is 
metabolised into prostaglandins and causes thymic atrophy
via their action, this thymic atrophy is absent when 
indomethacin is given. Indomethacin prevents the conversion 
□F arachidonic acid to prostaglandins [Meade, 1979].
Effects of compounds on the bone marrow can be 
ascertained by examining the transfer of bone marrow stem 
cells from pretreated animals into irradiated recipients or 
by i_n vitro colony formation assays [Metcalf eit al. , 1965;
Luster S Faith, 1979], Examples of such compounds are 
ethylcarbamate [Luster et al., 1982], 2,3,7,8,tetra- 
chlorodibenzo-p-dioxin [TCDD], diethylstilboestrol [DES] and 
benzo[a]pyrene [BP] which produce suppression of both 
cellular and humoral immunity [Dean et al., 1983]. TCDD 
affects foetal and neonatal rats and mice more severely 
than adults. This indicates that there are at least two 
critical periods for chemically induced injury to the 
immune system a] during the development of the immune system, 
usually a rapid onset effect, and b] post-development of the 
immune system, usually less severe and with delayed 
onset of effects. The toxic effects of 3,3*,4,4’ tetra- 
chloroazoxybenzene [TCAOB] are age-dependent, weanling rats 
showing greater thymic atrophy than 8 week old rats. This 
thymic atrophy is unaffected by prior adrenalectomy. TCADB 
produces some hypertrophy of the zona fasiculata of the 
adrenal gland but no morphological changes of the adrenal 
medulla. TCAOB causes a severe atrophy of the thymic 
cortex, leaving a pock-marked or " starry sky1' appearance 
in the remaining cortex due to the infiltration of macro­
phages. There is a lack of distinguishable thymic 
cortico-medullary boundary. Degenerative changes are seen
in the T-dependent areas of spleen and lymph nodes, but the 
B-dependent areas appear normal. TCAOB is a chemical which 
is thought to act on lymphocyte maturation at the thymic 
level [Hsla et al . , 1982] .
1 *9 dialkyl TIN COMPOUNDS, THEIR USES
Dialkyl tin compounds are used as heat and light 
stabilizers in many chlorinated plastics. Dioctyl tin 
derivatives were developed specifically for polyvinylchloride 
CPVC] items intended to come into contact with food. PVC 
foils made from hard PVC have been of particular use in 
packaging foodstuffs, as due to their high molecular polarity 
these foils have a low permeability to gas and water vapours 
with less'permeability for aromas, greater torsional strength 
and better "printability". The mechanism of PVC stabilization 
is complex, but one pathway is attributed to the ability of 
carboxylate ligands of the dioctylin tin compound to exchange 
with labile chlorine atoms present in the polymer during 
heat processing. The main compounds used for stabilizing 
food grade PVC are di-n-octyl tin iso-octyl maleate and 
di-n-octyl S,S-bis iso-octyl-mercaptoacetate. The last 
compound can be degraded whilst reacting with the PVC and 
liberate sulphur-containing products with the typical 
mercaptide odour. The first compound is therefore in 
greater demand for stabilizing food grade PVC. There is 
evidence that during stabilising PVC for heat processing 
and in contact with gastric juices the chemical DOTC is 
produced, making this the most commonly encountered stabilizer 
product from PVC that could affect man. These applications
raise the probability of migration of DOTC into foodstuffs
packed in such films. A model for such exposure has
indicated migrates of 80 jjg tin/kg medium [Figges jet al. 19 3
Sienen _et a_l. [ 1 976, 1 977a, b; 1 981 ] reported thymic
treated with DOTC
atrophy in WAG rats. They also noted a decrease in allograft
A
rejection and that the effect was not altered by prior
adrenalectomy CSienen ejt al. , 197'6], The phagocytes were
unaffected as measured by carbon clearance times. Sienen’s
group also reported that after feeding diets containing 150 ppm 
of DOTC
/>, for 4 weeks the effect was completely reversed within 2 weeks 
of cessation of treatment. Studies on ijn vitro cytotoxicity 
indicated that similar species and organ specificities were 
noted as had been in the ini vitro studies, i.e. bone marrow 
was unaffected while lymphocytes were killed. Sienen et al. 
1976, 1977a,1977b,1981] found no thymic atrophy in feeding 
Swiss mice with DOTC or DBTC.
Hennighausen S Lange [1979] reported that DOTC produced 
thymic atrophy in outbred ROZt mice, the response was dose 
dependent, completely reversible [within 22 days of 
cessation] and greater amounts of DOTC were needed by oral 
than intramuscular routes. DBTC produced similar thymic 
atrophy but with degenerative changes of the bile ducts 
[Hennighausen S Lange, 1979, 1980]. The toxic effects were
dependent upon the length of alkyl chain. The toxic effects 
on thymus and bile ducts were independent of each other in 
mice [Hennighausen S Lange, 1980],
There appears to be some difference between results 
obtained in different strains of mice [ROZt displaying thymic 
atrophy while there was none in Swiss mice]» but this could be 
due to the different dosage regimens used.
1 1 AIMS OF THIS STUDY
To evaluate the type, degree and time course of thym 
injury produced by DOTC in the male PVG rat using 
standard histopathological procedures routinely 
employed in toxicology and safety evaluation studies 
To assess the effects of this thymic injury upon 
immune functions in male PVG rats.
To assess the effects of age on this thymic injury 
and its reversibility.
To examine the histopathological changes using 
semi-thin plastic embedded sections at the light 
and electron microscope levels.
CHAPTER TWO
EFFECTS OF DOTC ON HISTOPATHOLOGY AND HAEMATOLOGY
2.1 MATERIALS AND METHODS
2.1.1 DOTC
Commercial grade DOTC was donated by Schering Chemicals 
CBillingshurst, G.B.]. Pure DOTC was purified by hydrolysis 
following US Patent 3.390.159 [1968] at the BIBRA 
laboratories.
2.1.2 Animals and Treatment
Male*inbred PVG rats were used in all experiments. The 
rats were obtained from Olac 1976 Ltd [Oxon] and were 
delivered to the BIBRA laboratories weighing 80-100 g 
[unless otherwise stated]. They were randomised using 
random number tables, earmarked and caged on arrival. The 
rats were allowed one week to acclimatise before the 
commencement of experiments. The control rats were fed on 
Spratts LAD No. 2 and the test rats were fed on Spratts LAD 
No. 2 containing 75 or 150 ppm DOTC for the time intervals 
of 2, 4, 8 and 12 weeks.
Food and water were available ad libiturn throughout the 
duration of all studies unless liver weight was being 
determined when the rats were starved overnight prior to 
killing. The body weight was determined once a week and food 
consumption was determined twice weekly.
The rats were housed in a room supplied ,'with 15 air
changes per hour supplied entirely From the exterior 
[no recirculation]. The temperature of the room was 
maintained at 22 + 3°C and the relative humidity of the 
room 60 + 15%. The light cycle was 12 hours light : 12
hours dark in phase with the natural cycle. At termination 
the rats were injected intraperitoneally with 6 mg pento­
barbitone/100 g body weight CSagatal 60 mg/ml pentobarbitone 
May and Baker] and then exsanguinated by aortal puncture 
with a 21 g syringe needle attached to a 10 ml syringe 
prefilled with 0.5 ml preservative-free heparin [Duncan 
Flockhart 1000 units per ml]. Body weight was determined at 
post mortem on a Mettler P.1200 top pan balance to an 
accuracy of + 0.5 g. Organ weights were determined on a 
Sartorius ' 1212 MP top pan balance to an accuracy of 
+ 0.0002 .g.
2.1.3 Histology
Tissue samples [thymus, spleen, lymph node, testes, 
epididymis, seminal vesicles and liver] For light microscopy 
were Fixed in buffered formalin [Sorensens phosphate buffer 
pH 7.2] or Bouin’s fluid. The tissues were processed through 
alcohols, embedded in paraffin wax, cut into 5 jj sections 
using a microtome, dewaxed, stained with haematoxylin and 
eosin and mounted with a glass coverslip and DPX using 
standard histological techniques [Carleton* s Histological 
Techniques, eds Drury and Wallington, 1967].
2.1.4 Haematology
Haematology was performed on blood obtained From the 
retroorbital plexus. A blood film was prepared, stained 
with May-Grunwald stain and evaluated under the light 
microscope [Practical Immunology, Hudso.n S Hay, 1976]. A 
sample of 40 _^il of blood was diluted 1:500 in Isoton 
[Coulter Electronics] and further diluted to 1:50,000 using 
a Coulter Dual Diluter III. The red blood cells in the 
1:50,000 dilution were counted on a Coulter Counter Model ZF. 
The red cells in the 1:500 dilution were lysed using 
Zapoglobin [Coulter Electronics] and the white cells counted 
using a Coulter model ZF. The haemoglobin level was 
estimated using the lysed dilution and a Coulter Haemo- 
globinometer. The Packed Cell Volume [PCV] and Mean Cell 
Volume [MCV] were determined by the HCT/MCV accessory 
connected to the Coulter Model ZF.
2.1.5 Statistics
Multivariate Analysis of variance was attempted because 
to treat each variable, i.e. liver weight, kidney weight etc., 
separately implies that each is independent of each other. Th 
organs of a living animal interact with each other. The data 
were mostly dominated by the highly significant values for 
the thymus. However, on removing this variable no further 
statistically significant results were observed using the 
multivariate approach.
2.2 RESULTS OF ORGAN WEIGHT STUDIES
Figures 2.1 and 2.2 demonstrate that both 150 ppm DOTC 
in the diet given to weanling PVG rats and 75 ppm DOTC in 
the diet given to 6-week old rats produced thymic atrophy.
A similar time course was observed in both studies. Liver 
and spleen weights remained unchanged by this treatment. 
Thymic weight loss was not apparent until 3-4 days after 
commencement of feeding with DOTC in either experiment and 
there was a dramatic weight loss until day 10-11. In the 
weanling rat given 150 ppm DOTC the thymic weight reached 
a minimum at day 10, however the 6-week old rat given 
75 ppm showed a further reduction in weight at 2 and 4 
weeks Ctable 2.1], When DOTC was given by gavage at! 100 mg 
DOTC/kg b o W .  C10 x the above dose] in corn oil [fig. 2.3] the 
onset of thymic weight loss was sooner and the reduction in 
rate of weight loss occurred earlier. The reduction in thymic
weight,/f0ilowed a similar time course for at least the j ;  
firs t 8 days whether additional daily doses were given or 
only the original dose was given. - Cfigs 2.3
and 2.4]. The food intake and weight gain of rats fed diet 
containing 75 ppm DOTC for 12 weeks were representative of 
the findings in all experiments [fig. 2.5]. There was a 
statistically non-significant drop in body weight of test 
rats compared with control rats, but no demonstrable 
alteration in food consumption. However, i t  will be seen 
from table 2.1 that exposure to 150 ppm DOTC for longer 
periods led to statistically significant reduction in body 
weight. The thymic weight was markedly reduced and there 
was a greater reduction with increasing exposure length to
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□DTC [table 2.1]. No difference in spleen weight was found 
between treated and control rats in these experiments.
The longer term experiments were carried out using 
75 ppm DOTC rather than 150 ppm to avoid loss in body weight. 
I t  will be noted from table 2.2 that after 4 weeks there was 
no further reduction in thymic weight. There was a slight 
increase in both absolute and relative liver weights 
which was only statistically significant at the 5% level 
for the relative organ weight after the longest peri.od of 
exposure [12 weeks]. Thethymic weight loss obscured all 
other variables when multivariate statistical analysis was 
attempted. There was an age effect on organ weights as 
might be expected as these rats were in a period of growth.
In table 2.3 the effect of 75 ppm purified DOTC was 
compared with the effect of 150 ppm commercial grade DOTC.
I t  will be seen that there was a similar reduction in thymic 
weight with no effect upon liver or spleen weight. The 
effect upon body weight was much less with the 75 ppm pure 
DOTC than the 150 ppm commercial DOTC far both time periods. 
This indicates that 75 ppm is a suitable dose for examining 
toxic effects on the immune system, as i t  caused thymic 
weight loss without affecting the weight of other organs.
2.2.1 The Effect of DOTC on Histological Parameters
Tissue sections of spleen, liver, prostate, seminal 
vesicles and testes from DOTC exposed rats were examined 
under the light microscope. No histological changes in these 
organs were attributable to treatment. When thymuses from 
DOTC exposed rats were examined, severe thymic atrophy was
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demonstrated with a loss of both cortex and medulla, a 
90% depletion of small thymocytes and a loss of the 
cortico-medullary boundary. The severity of 
the lesion was similar in all treated rats.
2.2.2 Results of DOTC Treatment on Haematological Parameters
Table 2.4 indicates that there was a reduction in WBC
at all lengths of exposure to DOTC but this was only
statistically significant after 2, 8 and 12 weeks of
treatment. The percentage of lymphocytes in the blood was
apparently decreased at all lengths of exposure, while the
percentage of neutrophils rose. tvVien the percentages
the results
were adjusted for the lowered WBC by expressing^ as absolute 
number of lymphocytes or neutrophils per ml of blood the 
decrease in lymphocytes is accentuated while the increase in 
neutrophils is diminished. Thus i t  would appear that there 
was a preferential loss of lymphocytes in the blood.
2.3 DISCUSSION OF RESULTS
The considerable delay between the start of administration 
of DOTC and the onset of thymic atrophy observed after the 
single or multiple high doses of DOTC could, in part, have 
been caused by slow or delayed absorption of the DOTC from 
the gastrointestinal tract. The absorption of orally 
administered tin and alkyl tins is known to be very poor in 
rats, the majority of the tin being excreted in the faeces 
without being absorbed CHiles, 1974; Hennighausen and 
Lange, 1979]. I f  absorption had taken place from the. caecum 
'and colon this could account in part for the delayed effect
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but i t  seems unlikely that this is the complete explanation 
as clearance time For orally dosed radiolabel is 24-48 
hours [Abrams and Bishop, 19673. Discrimination between 
delayed absorption From the gastrointestinal tract and 
delayed response could be resolved by intravenous 
administration oF DOTC. The dose oF DOTC would have to be 
reduced as the l-D^g is much lower For the intravenous than 
the oral route [again indicating poor absorption]
[Hennighausen and Lange, 1979]. However i t  is also possible 
that this delay may be caused by other Factors, such as a 
requirement For metabolic activation, aFFected cells taking 
a long time to die or action via the endocrine network.
The lack oF diFFerence within the First 8 days oF 
treatment aFter a single gavage compared to multiple dosing 
suggests there is a time lag not only in onset but also in 
reversibility indicating that recovery would be unlikely 
within the First Few days aFter cessation oF treatment with 
DOTC.
Although a slight increase in relative liver weight 
was observed no histological evidence oF tissue injury was 
Found. Since there was a slight reduction in body weight 
i t  is likely that this increase in relative liver weight 
is not indicative oF tissue response. Analysis oF hepatic 
enzyme activity would clariFy this point.
Although the slight decrease in body weight appeared 
consistently, there was no diFFerence in Food intake which 
implies that there was no gross eFFect on the appetite oF 
the rats such as would have occurred iF the diet were 
unpalatable but there may have been minor alterations or
poor Food utilisation caused by eFFects on the gut micro- 
Flora or gastrointestinal mucosa. '
The lack oF eFFect upon growth and absence oF 
histological diFFerences in testes and accessory sex organs 
between DOTC-treated and control rats indicates that there 
was no major upset to the endocrine system.
The histological studies also indicated that there was 
no depletion oF lymphocytes in secondary lymphoid organs 
[spleen or lymph nodes]. This together with the Fact that no 
reduction in spleen weight was demonstrated at any dose oF 
DOTC or exposure length to DOTC, can be taken as an 
indication that there was no proFound lymphocytic depletion 
as is seen in neonatal thymectomy or aFter administration oF 
some immunosuppressive drugs [Miller, 1962; DoenhoFF erfc a l., 
1979; Turk and Poulter, 1971; 5tockm.en st a_l. , 1973] and 
radiotherapy [Brent-^ S •'Medawar, 1366] .
The drop in numbers oF circulating lymphocytes appeared 
to have been proportional to the time since commencement oF 
exposure, with no recovery even aFter cessation oF DOTC 
administration. However, the maximum length oF exposure was 
12 weeks and the Fall in lymphocyte numbers was small even 
aFter 12 weeks exposure when compared with that seen in 
immunosuppressed individuals [Fauci 1975; Shih st al. , 1983].
The drop in lymphocytes would not seem to indicate that 
DOTC administration was likely to have produced a proFound 
immunosuppression. Longer recovery periods need to be 
examined to determine whether the drop in lymphocytes is 
transitory or permanent.
CHAPTER THREE 
EFFECT OF DOTC ON IMMUNE PARAMETERS
3.1 MATERIALS AND METHODS
Animals and their treatment were as described in 
Section 2.1 with the exception that allogeneic responses were 
assessed using an F1 hybrid produced From a Female PVS rat 
crossed with a male DA rat. These rats were maintained on 
Spratt LAD No. 2 at all times as per PVG rats.
3.1.1 Statistical Methods
A small sample Student’s t test was used to assess 
the signiFicance between test and control groups.
3.1.2 Humoral Response to Sheep Red Blood Cells CSRBC] a 
T-dependent Antigen
Sheep Red Blood Cells [SRBC] were used as a model oF 
a T-dependent antigen to monitor T-dependent antibody 
production. SRBC were obtained in Alsever's solution From 
Oxoid. 1 ml oF SRBC was placed in a round-bottomed tube 
C142AS Sterilin] and 9 ml Phosphate BuFFered Saline CPBS 
Oxoid Dulbecco’s A] added. The tube was centriFuged at 
700 g in a bench centriFuge For 5 minutes and the super­
natant discarded. CCare was also taken to remove the buFFy 
coat to remove any white blood cells.] The pellet was 
resuspended in 10 ml PBS and the tube centriFuged at 700 g
For 5 minutes and the procedure repeated. AFter the third
g
centriFugation the SRBC were resuspended to give 2 x 10
SRBC per ml [5% solution] and 0.5 ml was injected intra- 
peritoneally into a rat. The rat was injected in a similar 
manner 7 days later.
Blood samples were obtained From the retroorbital 
plexus under light ether anaesthesia at days 0, 7, 14 and 
21 aFter the First injection. The blood sample oF 0.5 ml 
to 1.0 ml was collected into an LP3 tube [Luckham], allowed
to clot, centriFuged at 700 g For 5 minutes and the serum placed
in another LP3 tube, stoppered and stored at -20°C until 
tested. The serum samples From each experiment were tested 
at the same time using a standard haemagglutination assay For 
IgM antibody to SRBC CHudson and Hay, 1976],
The serum was diluted serially using Flow Microtitre
dilutors with PBS as the diluent in round-bottomed micro­
titre plates CM24A Sterilin].
To each 25 pi serum dilution was added 25 pi oF washed 
SRBC suspension prepared as For the injections. The plates 
were incubated at 4°C For 3-16 hours. Wells with a 
deFinite button oF SRBC which moved due to gravity when the 
plate was placed at an angle were scored as negative. Wells 
which had no deFinite button, and which did not move when 
the plate was placed at an angle were scored as positive 
or agglutinated. The antibody titre was expressed as the 
Log^  oF the lowest dilution where
agglutination s t il l occurred.
3.1.3 Separation oF Mononuclear Cells From Blood
Approximately 5-10 ml aortal blood was obtained as 
detailed in section 2.1.1 and diluted with RPM1 1640 tissue
culture medium containing L Glutamine and 25 mM Hepes
buffer [Gibco] to give a final volume of 25 ml. The diluted
blood was layered onto 3 ml Ficoll-Paque CPharmacia GB] in
a round-bottomed tube [Sterilin 142AS]: four tubes were
used for each blood sample. The tubes were centrifuged at
600 g for 30 minutes at 4°C in a MSE Coolspin Centrifuge.
The interface layers containing the mononuclear cells from
two of these tubes were placed in a single 1 42AS tube and
the interface layers from the other two placed in another
1 42AS tube. The two tubes were centrifuged at GOO g for 10
minutes at 18°C and the supernatant discarded. The pellets
RPMI 16 40
were resuspended in 2 mi^ ana -che two tubes from each blood 
sample pooled, the discarded tube was washed with 6 ml RPMI 
1640 and the washing added to the resuspended cell pellets.
The tube was centrifuged at 600 g for 10 minutes and the 
supernatant discarded. The pellet was resuspended in 10 ml 
RPMI 1640 and centrifuged at 600 g for 10 minutes. The super­
natant was discarded and the cell pellet resuspended in 1 ml 
PBS for use in immunofluorescence or 1 ml Tissue Culture Medium 
[TCM] for use in Mitogen Induced Proliferation assays. An 
aliquot of 25 y i l was diluted 1:10 with WBC counting fluid 
[23.9 Handbook of Experimental Immunology 3rd Edition;
Weir, 1978] and counted using an Improved Neubauer 
Haemocytometer and a light microscope with a 40 x objective 
lens [Zeiss Jena]. The cell suspension was adjusted by
adding PBS or TCM to give 1 x 10^  cells per ml for immuno-
0
fluorescence and 1 x 10 cells per ml for Mitogen Induced 
Proliferation assay.
3.1.4 Preparation of Cell Suspension From Spleen
The spleen was excised aseptically, dissected free 
of fat and mesentery and washed in 10 ml RPMI 1640 
tissue culture medium [Gibco] in a sterile 50 mM petri 
dish. The spleen was then placed in a SO mm petri dish 
containing 10 ml RPMI 1640 and cut into 2-3 mm wide 
slices using a sterile No. 23 scalpel blade. The pieces o 
spleen were gently disrupted by a circular squashing 
action with the larger face of a sterile size E25 Silescol 
rubber bung [Esco Rubber, Sterilin]. The red blood cells 
were removed from the resulting cell suspension by step 
density gradient centrifugation and washed as described 
in section 3.1.3.
The cell pellet was resuspended in 3 mis PBS for
immunofluorescence and 3 mis TCM for Mitogen Induced
Proliferation assays respectively. An aliquot of 25 jul
was diluted 1:2Q with WBC counting fluid and counted as
described in section 3.1.3. The cell concentration of
the spleen cell suspension was adjusted with PBS to
1 x 107 cells per ml for immunofluorescence and with TCM 
6to 2 x 10 cells per ml for mitogen induced proliferation.
mesenteric
3.1.5 Preparation of Cell Suspensions FronyLymph Nodes 
The organ was excised aseptically, dissected free of
fat and mesentery and washed in 10 ml RPMI 1640 in a 30 mm 
petri dish. The organ was placed in another 30 mm petri 
dish containing 10 ml RPMI 1640 and gently teased apart 
with watchmakers forceps CArnold Horwell extra fine tips].
The resulting cell suspension was placed in a universal 
container and 10 ml RPMI 1640 added. The universal container 
was centrifuged at 600 g for 10 minutes at 18QC and the 
supernatant discarded. The cell pellet was resuspended 
in 20 ml RPMI 1640, centrifuged at 600 g and the super­
natant discarded. The cell pellet was resuspended in 1 ml 
PBS or TCM for immunofluorescence or Mitogen Induced 
Prolif eration assays respectively. An aliquot of 25 jjl was 
counted as outlined in Section 3.1.3 after being diluted 1:10 
with WBC counting fluid. The cell concentration was adjusted
Q
to 2 x 10 cells per ml with TCM for Mitogen Induced 
Proliferation assays.
3.1.6 Mitogen Induced Proliferation
When lymphoid cells are cultured with mitogens they 
are induced to transform from small quiescent lymphocytes 
into larger rapidly dividing blast cells. The reaction can 
be quantified by monitoring the incorporation of radio­
labelled precursors of nucleic acids, tritiated thymidine 
being the most widely used. The blastogenic response is 
thought to be a measure of the immune capacity of the lymphoid 
cells and different types of lymphocytes respond to different 
mitogens. Phytohaemagglutinin [PHA] is used as a general
stimulator of most T cells.
Foetal calF serum [Sera Labs batches 001003 or 101094] 
was inactivated by heating at 56°C For 20 minutes in a 
water bath [Grant] immediately prior to use. The Foetal 
calF serum batches were selected out oF 3 available samples 
For each batch as being the best able to support Lymphocyte 
ProliFeration Induced by Mitogens. Tissue culture medium 
[TCM] was prepared by adding 0.6 ml penicillin and 
streptomycin solution [10,000 units per ml, Gibco] and 5% 
heat inactivated Foetal calF serum.
Cell suspensions oF spleen, blood and lymph node
respectively
were prepared as detailed in sections 3.1.3, 3.1.4 and 3.1.5, 
using sterile techniques in a laminar Flow cabinet with all 
equipment being sterilised beFore use. The cell suspensions
g
were counted and adjusted to 1 x 10 cells per ml For blood
0
and 2 x 10 cells per ml For spleen and lymph nodes. An 
aliquot oF 100 yul oF cell suspension was added to each well 
oF a Flat-bottomed tissue culture microtitre plate 
[M29ARTL Sterilin], Phytohaemagglutinin [Wellcome puriFied 
grade batches K4515 or K9041] was used as a mitogen at 
concentrations oF 0, 0.8, 1, 2.5 and 5 y g /ml For spleen and 
lymph node, and 0, 2.5, 5.0, 7.5 and 10 j^g per ml For blood. 
Aliquots oF 100 y l  oF mitogen solution were added to the 
aliquots oF cell suspension in the microtitre plate. Five 
replicate cultures were set up For each cell type and 
dilution. The microtitre plates were placed in a 
23 x 23 cm plastic cake container [Stewart Plastics] and 
placed in a Flow gassed incubator. The incubator was 
maintained at 37°C with 5% 00^  in air atmosphere and an
humidity of 90%. Spleen, lymph node, and blood were 
cultured For 72, 72 and 48 hours respectively. Tritiated
thymidine CAmersham TRA 120, 1000 mCi/mMol] was diluted 1:20 
with TCM and 20 y l  oF this solution containing 1 j^Ci was 
added to each well B hours beFore the end oF the incubation 
period. The cultures were harvested using a MASH II cell 
harvester [Dymatech]. The process involved sucking the 
contents oF each well through a glass Fibre Filter CDynatech] 
and washing with 20 ml water per well. This leFt the 
insoluble DNA including incorporated radiolabelled thymidine 
on the Filter while washing through the unincorporated 
radiolabelled thymidine. The resulting glass Fibre disc 
was placed in an insert vial [Sterilin 505 or Packard 
Pico-Hang-I n] with 1 ml NE 233 scintillation Fluid [Nuclear 
Enterprises]. The sample was counted using a Packard 2650 
scintillation counter incorporating an internal programme 
which utilized a previously entered calibration curve and 
the external standard channels ratio to correct For quenching 
and determine counting eFFiciency. The activities oF 
replicate cultures were averaged.
3.1.7 Mixed Leucocyte Reaction [MLR]
PVG strain rats can recognise DA strain rats as 
histoincompatible as they diFFer at both the RT1 and RT2 
histocompatability loci.
An FI hybrid cross between a PVG Female and a DA male 
cannot recognise the PVG strain as histoincompatible as i t  
has PVG histocompatibility markers on its own cells. However 
a PVG rat recognises the DA histocompatability markers on
F1 hybrid cells as foreign and will mount an 
alloantigen reaction to such cells.
The MLR reaction is an in vitro measure of allogenic 
response and the inability of F1 to recognise parental 
strains as non-self is used to simplify the assay. When 
lymphoid cells are cocultured with lymphoid cells of a 
histo-incompatible strain there is an allogenic response 
which can be measured by the incorporation of tritiated thy 
midine.
A suspension of blood cells from the PVG rats whose
ability to mount allogenic cell reactions was being tested
[and age matched controls] was prepared as outlined in
section 3.1.3 and a similar cell suspension was prepared
from F1 hybrid rats [the F1 suspensions were pooled]. The
6cell suspensions were adjusted to 2 x 10 cells per ml with 
TCM. Aliquots of 100 1^ of PVG cell suspension were placed 
in eight wells of a flat-bottomed microtitre plate 
[M29ARTL] and 100 jjl PVG cells [control] was added to 4 of 
the wells and 100 jjl F1 cells [test] was added to 4 of the 
wells and 100 y l  F1 cells [test] was added to the other 4 
wells. The plate was cultured in an incubator as outlined 
in section 3.1.G for 5 days. Tritiated thymidine was added 
[as in section 3.1.G] 16 hours before the end of incubation 
Harvesting and counting were performed as outlined in 
section 3.1.G. The activities of replicate cultures were 
averaged. •
3.1.8 Graft versus Host Reaction [GvH]
This utilises the relationship between PVG and F1 
[PVG x DA] rats explained in the previous section. GvH 
is an ijn vivo test for allogeneic response, immunocompetence.
A modified form of the assay used by Ford eat al. [^ 970] 
was utilized. Parental strain lymphocytes [which are 
immunocompetent cells] are injected into the footpad of 
an F1 recipient and the allogeneic response is measured by 
the increase in size of the draining popliteal lymph node.
Mesenteric lymph nodes from PVG rats were excised, 
dissected free of fat and mesentery, placed in 5 ml PBS 
and gently disrupted in a duo-dual surface ground glass 
tissue homogeniser with large clearance [Jencons]. The 
cells were suspended in a further 20 ml PBS and placed in a 
universal container [S28A Sterilin]. The universal container 
was centrifuged at 600 g for 10 minutes and the supernatant 
discarded. The cell pellet was resuspended in 25 ml PBS and 
centrifuged at BOO g for 10 minutes and the supernatant 
discarded. The cell pellets from rats which had had the 
same pretreatment were pooled and resuspended in a total of 
25 ml PBS, centrifuged at BOO g and the supernatant 
discarded. The pooled cell pellet was resuspended in 1 ml 
PBS, an aliquot counted as in section 3.1.3 and the cell
sconcentration adjusted to 1 x 10 cells/ml. An aliquot of 
0.1 ml of pooled standardised cell suspension or PBS 
respectively was injected subcutaneously into the right and 
left hind foot pads of an F1 hybrid rat. The F1 rat was a 
male aged 7-8 weeks old produced by mating a PVG female with 
a DA male. A tria l experiment demonstrated no significant
difference between a suspension of F1 cells and PBS, so PBS 
was used to cut down the preparation time.
The F1 rats were killed by ether anaesthesia 7 days 
later and the popliteal Cdraining] lymph nodes excised, placed 
in PBS until they could be dissected free of fat, blotted 
dry and weighed on an Oertling R41 electric beam balance 
to an accuracy of + 5 mg.
The Proliferation Index =
i
weight of PVG [right] injected LN test 
weight of PBS Cleft] injected LN [control],
3.1.9 Immunofluorescent Enumeration of Lymphocytes
Murine monoclonal antibodies to the different surface
i
antigenic determinants of rat T-lymphocyte subsets are 
commercially available [Sera Labs]. The two used were 
VI3/2.S which recognises T-Helper cells and those cells 
involved in allogenic immune reactions and OX/8 which 
includes suppressor subsets. Very few rat T-lymphocytes 
bear both surface antigenic determinants. Those cells 
bearing these surface antigenic determinants or expressing 
the W3/25 and OX/8 phenotypes can be quantified by immuno­
fluorescence using an indirect method with fluorescein 
conjugated rabbit anti-mouse immunoglobulins.
The cell suspension to be evaluated was prepared as 
in section 3.1.3. After the final centrifugation the 
pellets were resuspended in PBS and the cell concentration 
adjusted to 1 x 10^  cells per ml. Aliquots of 100 j^1 
of cell suspension were added to LP3 tubes. Rabbit anti-rat
immunoglobulin [Ra R Ig Miles] was diluted 1:50 with 
PBS containing 0.05% of sodium azide [PBSf] and aliquots 
of 100 yul added to the LP3 tubes containing 100 jjl cell 
suspension. The suspensions were incubated at 4°C for 45 
minutes. The Ra R Ig was used to decrease non-specific 
staining. The cell suspension was resuspended in 2 ml 
PBSf and centrifuged at 300 g for 5 minutes. The cell 
pellet was resuspended in 2 ml PBS, centrifuged at 300 g 
for 5 minutes and the supernatant discarded. The cell 
pellet was resuspended in 100 j j l  PBSf and 100 j j l  monoclonal 
antibody solution added. CThe monoclonal antibodies were 
all diluted 1:100 with PBSf]. The cell suspension was 
incubated at 4°C for 45 minutes. The cell suspension was 
washed twice by centrifugation at 300 g with 2 ml PBSf as 
detailed above. The cell pellet was resuspended in 100 j j l  
PBSf and 100 j^l fluorescein isothiocyanate conjugated 
rabbit anti-mouse immunoglobulin [FITC anti-Mouse Ig 
Miles] diluted 1:50 with PBSf. The cell suspension was 
incubated at 4°C for 45 minutes and washed twice by centri­
fugation as detailed above. The cell pellet was 
resuspended in 50 j j l  glycerol buffered with 10% PBS and with 
0.1% P-phenylene-diamine [BDH] added to reduce fading. The 
cell suspension was placed on a microscope slide, mounted 
with 22 x 32 mm coverslip and the edges sealed with hot 
paraffin wax. The slide was examined under phase contrast 
and ultraviolet [UV] light on a Zeiss Photomicroscope I POL. 
The percentage of 200 cells counted under phase contrast which 
fluoresced under UV light was calculated.
3.2 RESULTS
3. 2.1 Humoral Response to a T-dependent Antigen
In the preliminary experiment [fig. 3.1] r'a'ts 
were immunized to SRBC after 4 weeks exposure to diet 
containing 150 ppm DOTC and bled at intervals of 7 days.
There was no statistically significant difference in 
antibody titres between DOTC-exposed and control rats. The 
results of the experiment involving longer exposure to 
DOTC in which the immunization and blood samples were taken 
during exposure to guard against there being only a 
transient effect of 00TC on humoral response, [fig. 3.2] 
indicated that there was no aberration in humoral response 
to a T-dependent antigen under any of the regimens utilised.
3.2.2 Quantification of T-lymphocyte Subsets by Immunofluorescence 
The results in table 3.1 were obtained when this 
technique was used on blood lymphocytes separated from rats 
exposed to 150 ppm DOTC for 8 and 12 weeks respectively 
as shown in table 3.1. At both time intervals the percentage 
W3/25 phenotype cells had decreased while the percentage of 
OX/8 phenotype cells had risen [statistically significant 
at the 5% level after 12 weeks]. When allowance was made for 
the drop in leucocytes, and the results expressed as numbers
of surface antigen determinant bearing cells per ml of
th e
blood, i t  was seen that rise in OX/8 phenotype cells was
A
negligible whereas the drop in W3/25 phenotype cells was 
quite marked and statistically significant at the 1% and 
0.1% levels for 8 and 12 weeks DOTC exposure respectively.
Fig
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3.2.3 Graft versus Host Reaction
Figure 3.3 shows the effect of the number of injected 
PVG or F1 cells on the weight of the draining lymph node 
of an F1 recipient. There was a dose-dependent increase 
in weight with PVG cells but no increase with F1 cells.
The dose of 5 x IO"7 cells was selected for the main 
experiment. Table 3.2 shows the results of GvH carried 
out using PVG cells from rats pretreated with a diet 
containing 75 ppm DOTC for 8 weeks. There was a slight 
drop in lymph node weight compared to cells from control 
rats which was more discernible when expressed as the 
index of proliferation which gives a measure of the increase 
in popliteal lymph node weight. The F1 were all selected 
to be of the same age and sex. Figure 3.4 demonstrates 
that there was no significant difference between test and 
control rats of both donor and recipient groups in terms 
of body weight and weight gain. The food intake of the DOTC 
exposed donors was actually identical to the control donors.
3.2.4 The Mixed Leucocyte Response
When the MLR assay was performed using PVG responder
lymphocytes and an F1 hybrid [PVG x DA] stimulator cells
i t  was found that the optimal response was obtained with 
54 x 10 cells per well [fig. 3.5], When the PVG responder 
strain cells were obtained from rats given diet containing 
75 ppm DOTC for 8 weeks, the MLR was markedly reduced 
compared to that produced by age-matched controls C i^g-3.6].
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Table 3.2 Effect of DOTC on Graft versus Host Assay
G wk old PVG rat given diet containing 75 ppm DOTC for 8 wk
Wt of F1 popliteal 
lymph node in mg
vehicle L.N. test L.N. P.I. n
Untreated PVG 
rat 5.74 + 0.29 111 . 41 + 5.34 18.87 + 0.99 27
DOTC treated 
PVG rat 5.85 + 0.25 101.84 + 5.46 17.61 + 1.09 28
wt of test l.n. 
Proliferation Index = -------------------------------------
wt of vehicle l.n.
Fig 3.4 FOOD INTAKE AND GROWTH
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Fig 3.6
EFFECT OF D IETARY D O TC  ON 
MIXED L E U C O C Y T E  RESPONSE
5 d culture of inbred
and F1 hybrid cellsControl
6 wk old rat given 
75 ppm for 8 wk
Treated
i
Allogeneic Syngeneic Allogeneic Syngeneic
Cell Reaction Cell Reaction
n = 1 6
3.2.5 Mitogenic Blastogenesis
The blastogenic response to PHA was assessed on 
lymphocytes separated from rats which had been exposed to 
□QTC in the diet for 2, 4, 8 and 12 weeks and table 3.3 
shows that the dose response curve to PHA differed for 
splenic and blood lymphocytes. The incorporation of 
tritiated thymidine was reduced after only two weeks 
exposure to DOTC and the greatest decrease was seen at 
suboptimal PHA concentrations. There was a similar decrease 
in PHA-induced blastogenesis after 4 weeks Ctable 3.3] end 
8 and 12 weeks [table 3.4] exposure to DOTC. Similar results 
Ctable 3.5] were seen when rats were exposed to purified 
DOTC for 2 and 4 weeks. The variability was high and thus 
the results were not statistically significant. However i t  
must be noted that the lymphocytes were cultured at a 
standard concentration of cells per ml of culture fluid to 
reduce variation due to the kinetics of the response and no 
allowance was made for the reduced numbers of lymphocytes 
found in the blood Ctable 2.4]. Thus i t  would appear that the 
ability of lymphocytes from rats treated with DOTC to respond 
to plant mitogens is reduced after even 2 weeks exposure.
Table 3.3 Effect; of DOTC on Mitogen-induced Blasto genesis
2 weeks 150 ppm 00TC
Spleen n Control n T est % Control
•
□ 8 1090 ± 707 8 430 + 187
0.8 8 46401 ±105237 8 3212 + 4052 6.9
2.5 8 264808 +150318 8 170406 + 141107 64.3
5.0 8 125541 ± 95512 8 116038+ 77305 92. 4
Mes. LN
•
0 8 2598+ 1241 8 2681 + 1106 !
0.6 8 267531 ± 269070 8 93932 + 11 4311 35
1 .25 8 284250 + 367519 8 141611 + 164328 50
3.75 8 217650 + 332287 8 61864 ± 65084 28
Blood
0 * 8 635 + 408 7 1232 + 801
2.5 8* 132097+ 83423 7 87061 ± 58732 66
5.0 8 243817+ 111113 7 209677± 181645 85
12.5 8 379330+ 177008 7 271049 ± 206174 54
4 weeks
Blood •
0 # 8 199 + 8B 9 321 + 96 !
2.5 8 21137 + 13964 9 6921 + 5113 33
5.0 8 85856 + 50178 9 54582 + 45775 64
12.5 8 116000+ 91612 8 22795 ± 28488 20
Mean dpm + Standard
Mes = Mesenteric
w ____ ____________________________________________
PHA concentration - ’•! t : i n  pg/ml
T a b l e  3 . 4  E f f e c t :  o f  d i e t a r y  DOTC o n  M i t o g e n - i n d u c e d
b l a s t o g e n e s i s
8 weeks exposure to 75 ppm DOTC in the diet 
Blood lymphocytes 
PHA cone Control mean + SC
pg/mi □PM n
Test mean + SC? 
□PM n Control
0 883 + 660 10 859 + 511 7
2.5 17177 + 15919 10 4596 + 2652 7 27
5.0 55733 + 39642 10 23463 + 9487 7 42
7.5 73429 + 52361 10 46342 + 27462 7 63
12 weeks exposure to 75 ppm□0TC in the diet
Q 945 +281 - - - 8 459 + 109
2.5 23168 + 4394 8 . 5913 + 1350 8 'ZS
5.0 60955 + 10739 8 27421 + 3758 7 45
7.5 78236 + 14676 8 50627 + 15421 8 64
10.. 0 71273 + 15945 8 40287 + 5825 7 57
T a b l e  3 . 5  E f f e c t  o f  P u r i f i e d  DOTC o n  M i t o g e n - i n d u c e d
B l a s t o g e n e s i s
PURE DOTC
2 weeks
A C n T n % Control
□ 302 + 115 10 224 + 54 8
2.5 SO 46 + 8421 10 4464 + 5191 8 49
5.0 25261 + 18210 10 21329 + 12112 8 84
10.0 46118 + 28480 10 30250 + 1 4912 8 66
4 weeks
□ 396 + 180 10 373 + 131 10
2.5 20453 + 21738 10 12420 + 20 431 10 61
5.0 71792 + 54227 10 74451 + 96922 10 103
10.0 90168 + 54132 10 1 46741 + 205621 10 163
Figures are mean + Standard and are in DPM
PHA concentration in jjg/ml j
3.3 DISCUSSION OF RESULTS
The antibody response to SRBC Ca T-dependent antigen] 
was neither statistically nor biologically significantly 
reduced by feeding diet containing DOTC for up to 12 weeks.
There was a slight reduction after 12 weeks exposure which 
might indicate the start of a decline in antibody titre in 
response to newly encountered antigen, such as was seen when 
antigens were injected some time after adult thymectomy, for 
example the decline in antibody production noted by Roupe 
[1978] 2 to 5 months after adult thymectomy. The longest 
exposure to DOTC before immunisation with SRBC in these 
experiments was 9 weeks,and i t  is possible that antibody 
titres to SRBC challenge after 6 months of DOTC treatment 
would show whether there is a decline in antibody production. 
However, in the above studies the antibody titres showed that there 
was lit t le  immediate or profound effect upon antibody 
production which indicates that both the regulatory helper 
T cell responsible for initiating antibody response to SRBC 
and the plasma cells Cdeveloped from B lymphocytes] which 
produce the antibody were not affected by DOTC treatment.
Thus one would assume that T-independent antibody production 
would also tend to be unaffected by DOTC treatment. Neonatal 
thymectomised mice [Miller, 1961] and nude rats CFesting,
1981] both had a depressed antibody response to T-dependent 
antigens but no impairment in antibody production to 
T-independent antigens was seen.
The analysis of T-cell subsets by immunofluorescence 
indicated that a preferential loss of W3/25 phenotype cells 
occurred after DOTC treatment. The W3/25 phenotype cells
have been shown to include those T-lymphocytes responsible 
For T helper regulatory Functions, allogeneic MLR
and GvH reactions [White e rt jal. , 1978]. The preferential
loss of the T lymphocyte subset and the lack of effect upon 
antibody response suggest that DOTC is not causing any 
major impairment to lymphopoiesis since this would affect 
both B and T lymphocytes. I t  would therefore appear that 
there may be a defect in T cell maturation.
The allogeneic responsiveness was examined using two 
test systems, the GvH and MLR assays. There was a slight 
reduction in the Proliferation Index [PI 3 of lymph nodes 
draining the site of injection of PVG lymphocytes from rats 
pretreated with DOTC into a histoincompatible F1 host 
compared to the PI produced by injection of lymphocytes 
from control PVG rats. This was, however, not as marked 
as to suggest that the allogeneic responsiveness of 
□OTC-treated rats was impaired, so as to render them incapable 
of mounting successful responses to allogeneic challenges. 
However, when the in vitro MLR assay was performed the 
lymphocytes from DOTC treated rats had considerably reduced 
proliferation in both syngeneic and allogeneic cultures 
compared to lymphocytes from control rats. Both allogeneic 
responsiveness assays demonstrated a decrease, but to 
differing degrees. The difference in degree of decrease 
could be representative of the relative sensitivity of the 
two assays or i t  could be due to the different sources of 
lymphocytes used in each assay. The GvH assay uses mesenteric 
lymph node cells whereas the MLR assay uses lymphocytes 
separated from peripheral blood. As a reduction in
circulating lymphocytes is apparent while histologically 
no depletion is seen in the T-dependent areas of secondary 
lymphoid organs, i t  could be thought that the blood shows 
alterations in lymphocyte numbers and proportions of 
subsets before other lymphocyte compartments of the body. 
Perhaps the reduction in PI would have been greater i f  
blood rather than lymph node was the source of donor 
cells for the GvH assay, as there was a reduction in 
lymphocytes in the blood but no lymphoid depletion in the 
secondary lymphoid organs [Chapter 2].
The MLR assay was set up with a constant number of 
lymphocytes per well to guard against changes caused by 
different cell concentrations [Farrant and Knight, 1979].
The MLR could thus be underestimating the depression in 
allogeneic reactivity in the blood. Also no allowance was 
made for the alteration in proportion of T cell subsets.
The treated rats would not be regarded as immunocompromised 
with regard to allogeneic reactions. This lack of immuno- 
compromisation indicates that DOTC is not causing a profound 
immunosuppression as is seen with some drugs [ Shih _et aJL. , 
1983]
The proliferation response [as measured by tritiated
thymidine incorporation] after stimulation with the mitogen
PHA was reduced at all DOTC doses and lengths of exposure.
The greatest effect was seen at suboptimal doses of PHA.
The observation that greatest reduction in incorporation of
thymidine I was found at the suboptimal doses could be due
these
to a number of factors, include lowered threshold of 
activation for cells producing so-called helper factors
and thus lowered concentration of such Factors, the 
requirement For a minimum number of activated cells per 
unit area For proliferation, or suppressor cell function 
being triggered at a lower mitogen concentration than that 
needed for helper cell activation. This could mean that 
suboptimal concentration of PHA is a more sensitive 
indicator of impairment of T cell function than the optimal 
PHA concentrations. PHA response has long been used as a 
measure of lymphocyte function and this depression in the 
response to PHA caused by OOTC indicates that there is a 
DOTC associated decrease in the ability to respond to immune 
stimuli. Mitogen assays have been criticised as being an 
in vitro assay and thus prone to influences of the culture 
environment which are not present in the intact animal. 
However, the depression in allogeneic responsiveness together 
with the reduction in PHA response caused by DOTC indicated 
that DOTC caused a slight depression in the immuno- 
competence of treated rats. This depression is not as great 
as would be seen in immunosuppressive therapy but could 
indicate decline in cell mediated immune responses.
Disturbances in immune regulation have been shown to 
cjive rise to an increased incidence of autoimmune diseases,
decreased
^ability to resist infections and an increased incidence of 
inappropriate immune responses [Taylor, 1964; Ruebush and 
Hanson, 1980; Ahmed Penhale, 1982; Bach and Charreire, 1979]. 
Thus the effect of long-term exposure to DOTC on autoantibody 
levels, host resistance and the ability to induce tolerance 
would appear to be useful areas for further studies.
CHAPTER FOUR
EFFECT OF AGE ON DOTC-INDUCED THYMIC INJURY 
AND THE REVERSIBILITY OF DOTC-INDUCED THYMIC INJURY
4.1 MATERIALS AND METHODS
4.1.1 Animals and Their Treatment
The rats used and their treatment was as detailed in 
Section 2.1.1 with the Following exceptions. In the 
experiments where age was a variable the rats were obtained 
From Olac at the weight ranges 40-60, 80-100, 120-140 For 
the First experiment and 40-60, 100-120 and 180-200 g For
the second experiment. The rats were 4, 6 and 7 weeks old 
and 3, 6 and 8 weeks old at start of DOTC exposure 
respectively. The rats used in the second experiment 
commenced Feeding with DOTC-containing-diet on arrival 
rather than one week after arrival. Haematology and post 
mortem procedure was also as detailed in Chapter Two.
4.1.2 Statisti cs
Two way analysis of variance [AN0VA] was used. The 
experiments were designed with two variable factors in mind 
- the effect of age/time and the effect of treatment. The 
experiments were designed to have equal numbers of 
samples/animals in each Cage/treatment] combination. Some­
times data on a particular parameter was missing due to 
unavoidable circumstances but the statistical package used
•to evaluate the data was able to cope efficiently with the 
few missing data points.
4.1.3 Methods for In Utero Exposure Study
Female PVG rats arrived at the BIBRA Laboratories 
in the 4-5th day of pregnancy having been mated with male 
PVG rats. The female rats were placed on diet containing 
75 ppm pure DOTC Ctest] or control diet CGroup 1]. The 
test mothers remained on DOTC diet until either the pups 
were born [Group 2] or the pups were weaned CGroup 3] . As 
many pups as possible of those that died in the firs t few 
days of life  were examined for appearance of thymus and 
spleen. The mothers were housed individually in solld- 
-bottomed plastic cages with suitable littering material.
The pups were weaned 3 weeks post partum and the 
female pups killed and examined for appearance of thymus. 
The male pups were randomised accordingly within groups and 
ear marked and put on SIDS No. 2 diet Call groups]. At 12 
weeks of age, 4 rats were killed per group. The mothers 
were allowed 7 weeks post partum to recover and then killed 
and the thymuses examined.
4.2 RESULTS
4.2.1 Effect of Age and Dose of DOTC on Pathological 
parameters
Table 4.1 gives the mean values obtained when PVG rats 
aged 4, 6 and 7 weeks old were fed diet containing □, 75
or 150 ppm DOTC for 2 weeks. The most dramatic effect was
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in the reduction in thymic weight which appears to be dose 
related and age-dependent being greatest at the highest 
dose of DOTC and in oldest rats. Tables 4.2 and 4.3 
compare the effect of age and dose on relative organ 
weights and haematological parameters. I t  is noted that 
there was only an effect of age on body weight at the start 
of experiment, accounting for 96% of the variance, however 
at the end of the experiment there was a significant effect 
of treatment on body weight as well as age and when this 
is examined in terms of weight gain during the course of 
the experiment i t  will be seen that there was a dose- 
related decrease in weight gain due to treatment.
The relative weight of the liver was decreasing with 
age but there was a DOTC-induced increase in weight. The 
spleen was also decreasing in relative weight with increasing 
age and there was a further treatment-related decrease in 
relative weight. The testes were decreasing in relative 
weight with increasing age, but there was a DOTC-induced 
increase. In body weight, relative liver, spleen, 
testes,and prostate weights, there was no interaction 
between age and DOTC effects. However, there was an 
interaction between DOTC and age effects with relative 
seminal vesicle weight. The seminal vesicles as with the 
prostate, increased in relative weight with age, but whereas 
DOTC caused a drop in prostate weight therewas a drop at 
75 ppm DOTC, but an increase at 150 ppm DOTC. The 
haematological values showed no alterations caused by DOTC 
treatment but there was a slight increase in WBC and RBC
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Table 4.3 Effect of Age on Pathology of PVGRats af ter
Exposure to Diet containing 0, 75 or 150 ppm
DOTC for 2 Weeks
% Variation due to DOTC Treatment and/or Age
DOTC LIN QUAD AGE D/A Residual
BWS 0.05
NS
0.00
NS
0.05
NS
96
^ s'/ O/
0.94
NS
3.00
BWF 4. 14
-T* *V*
4.03
+*+ nL
0.12
NS
87.39
sl/st^
1 .36 
NS
7.12
Wt. Gain 28.44 28. 40 0.04
NS
29.81
S«y sty st
3.34
NS
38. 42
Rel. Thy. 86.59
<*.»*
72.94
^
13.65
^ ^•’i"* 'I'
5.27
sty Oy. S.L
y <r* t
5.98 2.24
Rel. Liver 9.58 9.07 0.51
NS
60.51 2.80
NS
27.12
Rel.Spleen 10.10 10.10 0.00
NS
48.11
sly sty «Jy»
8.27
NS
33.52
Rel.T estes 13.80 11 .42 2.37
NS
54.94
+1+
3.83
NS
27. 43
Rel.
Prostate
20.95 16.08
^ ^
4.87 67.43
sly sty *,»/
2.45
NS
14.35
Rel. Sem. 
Vesicle
19.03
%t> -L
12. 43
vL O/
6. 60 48.62 14.96 17.38
PCV 12.13 
NS
10.56 1 .57 
NS
4.26
NS
18.21• 
NS
67.76
WBC 0.18
NS
0.01
NS
0.17
NS
18.68
sty"|S
12.16
NS
68. 98
RBC 1 . 76 
NS
0.30
NS
1 . 46 
NS
43.67
sty sly ^ly
6.34
NS
48.22
'\' = Significant: at 5% level
** = w " 1% level
** ■ ” ** 0.1% level
NS = Not statistically significant
with increasing age.
To sum up, thereWas a slight effect of DOTC on body 
weight, weight gain, and relative liver, spleen, testes, 
seminal vesicles and prostate weight but this did not 
appear to interact much with the age-dependent changes in 
organ weights, however thereWas a marked decrease in 
thymus weight caused by DOTC and this appeared to be reduced 
to a smaller value in older rats. Therewas no effect of 
□OTC on haematological parameters - this was also what was 
found in earlier experiments at this time interval of DOTC 
exposure. There appears to be some relationship between 
the age of the rat and final thymic weight post atrophy- 
-weanling rats being less severely affected - but the values 
are not statistically significant.
4.2.3 Reversibility of DOTC-induced Effects
The figure 4.1 indicates that after the tenth week of 
life  the thymus was decreasing in weight. Male PVG rats 
pretreated with 75 ppm DOTC for 4 weeks showed some gain in 
weight after cessation of exposure, but this ceased after 
4 weeks and the thymus began to involute at a rate similar 
to that of untreated rats, but never returning to the same 
weight as the age-matched control rats’ thymuses. The 
differences are accentuated when the thymus weight is 
expressed relative to body weight [figure 4.2],
However, i t  will be seen that there is no effect of 
□OTC-treatment on the spleen before, during or after 
recovery [figure 4.3]. Therewas a drop in absolute 
lymphocytes [% lymphocytes x WBC/100] but no alteration
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Fig 4.4
EFFECT OF POST-TREATMENT RECOVERY ON 
LEUCOCYTE NUMBERS
6 wk old PVG rat fed diet containing 75 ppm DOTC
for 4 wks
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in absolute neutrophils.: The absolute values of lymphocyte numbers
-ed        *• '
remain^ below the controls even after 2G weeks post-treatment
recovery. This indicates that in the B-week-old male PVG
rat the thymus weight and number of lymphocytes per ml of
blood do not return to the same values as age-matched
controls within 20 weeks. The result contrasts with the
work of Sienen ^t sal. [197Z] but the experiments differed in
the strain and age of rats used.
4.2.3 Effect of Age on Recovery from DOTC-induced Effects
Tables 4.4 and 4.5 indicate that taking male PVG rats
; a£e
with a wider^ range than those in 4.2.1, similar effects 
were demonstrated - a decrease in weight gain, increase in 
relative testes and liver weights, decrease in relative 
spleen weight with DOTC exposure. The major effect was a 
dramatic reduction in relative thymus weight which was 
again reduced to the lowest value in the older rats, although 
there was a lower net weight loss. When the parameters 
were examined in animals which had undergone 4 weeks post 
treatment recovery [tables 4.6 and 4.7] i t  was noted that 
body weight was s t il l reduced in DOTC-pretreated rats, 
relative testes and liver weights remained higher in DOTC 
pretreated rats than in age-matched controls whereas 
relative spleen weight was reduced in the older rats but 
increased in younger rats.
There was a reduction in WBC in all groups but this 
was only statistically significant in the 6-week-old at the 
start of the experiment. However, when relative thymus
Table 4.4 Effect of Age on Body Weight, Organ Weight 
Relative to Body Weight and WBC Count after 
Exposure to Diets Containing 75 ppm Pure DOTC 
for 4 Weeks.
Age at commencement of treatment 
3 weeks 6 weeks 8 weeks
Body weight C 1 49 + 5.2 208 + 6 261 + 8
T 129 + 7 180 + 2 243 + 5
Thymus weight C 192 + 20 127 + 8 87 + 2
T 37 + 4 11 + 5 12 + 1
Spleen weight C 260 + 7 229 + 6 237 + 18
T 234 + 6 228 + 5 246 + 21
Testes weight C 1417 + 27 1234 + 41 1028 + 29
T 1621 + 48 1373 + 1 1086 + 30
Liver weight C 5481 + 351 4935 + 450 3961 + 212
T 5132 + 108 4757 + 84 4266 + 82
WBC C 7.2 + 0.8 6.5 + 0.3 6.9 + 0.6
T 5.3 + 0.1 6.1 + 0.5 9. 4 + 1 .2
Weight gain C 99.25+ 4.29 103.5 + 5.95 66.5 + 4.65
T 75.5 + 5.81 72 + 5.03 44.75+ 3.20
C = Control 1 n=4
T = Test
Body weight and weight gain in g; organ weightin 
mg/100 g body weight.
—2 3WBC = White Blood Cell numbers 10 /mm
Table 4.5 Analysis of Variance on Data shown in Table 4.4
Age T reatment Age/Treatment
Body wt 0.0005 0.68
^ «.»> «J> "1' NS
Thymus wt 0.0001 0.0016
O/ O/
Spleen wt 0.36 0.55 0.38
NS NS NS
T estes wt 0.0001 0.0002 0.12
 ^'Is NS
Liver wt 0.0011 0.75 0. 45
NS NS
WBC 0.018 0. 98 0.0079
NS
* = Significance at 5% level
** = w " 1% level
" M 0.1% level
NS = not significant
Table 4.6 Effect of Age on Recovery from being given Diet 
containing 75 ppm Pure DOTC for 4 Weeks with 4 
Weeks Post-treatment Recovery
Age at Start of Treatment in Weeks
3 6 8
Body wt C 241 + 4 273 + 10 297 + 7
T 212 + 13 260 + 6 285 + 11
Thymus wt C '109 + 5 88 + 6 68 + 5
T 112 + 7 59 + 4 34 + 2
Spleen wt C 211 + 4 21 4 + 4 239 + 17
T 234 + 5 204 + 7 194 + 3
T estes wt C 1101 + 23 1009 + 29 892 + 39
T 1220 + 39 990 + 26 992 + 41
Liver wt C 4613 + 140 4240 + 1 45 3933 + 171
T 4695 + 85 4852 + 295 4486 + 258
WBC C 10.7 + 1 .2 10.2 + 0.4 11.0 + 1.0
T 7.4 + 0.4 7.7 +' 0.5 8.3 + 0.4
Weight C 193.75 + 5.59 164.5 + 11.44 102.75 4 4.23
gain T 164.5 + 9.95 154.25+ 7.06 92.5 +11.86
C = Control in=4i
T = T est
Body weight and weight gain in g; organ weight in 
mg/100 g body wt.
-2 3WBC = White Blood Cell numbers >c 10 /mm
T a b l e  4 . 7  S t a t i s t i c a l  A n a l y s i s  o f  T a b l e  4 . 6
Age Treatment Age/Treatment
Body weight 0.0001 0.0213
V
0.6271
Thymus weight 0.0001 
v L  v L  J *"r "r 'i'
0.0001 0.0249
Rel.Thymus weight 0.0001
*v ■’r "r
0.0002 0.00 40
V *T*
Spleen weight 0.0055 0.0157 0.0974
Rel. Spleen weight 0.2936 0.1333 0.0021
Rel. Testes weight 0.0001
 ^ o.-v
0.0252 0.1153
Liver weight 0.0537 0.5522 0.2277
Rel. Liver weight 0.0879 0.0182
' I s
0.3569
WBC 0.5066 0.0002 0.8523
* = Significant at 5% level
.W, _ lf» l|»'1'— 1% level
0.1% level
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Table 4.9 Effect of DOTC in diet during Pregnancy on
Pup Numbers
Group Mean No. of Pups n
Control 9 + 2.8 9
T est 6.53 + 3. 41 15
NS
NS = Not Significant
Dams received 60 ppm DOTC in the diet during pregnancy
weights were examined, the 3 week at start of experiment 
[weanling] rats had recovered, whereas the 6 and 8 week at 
start rats had not. This could explain the discrepancies 
between the earlier work [3.2.1] and that of Sienen _et al. 
[1977], The post-weanling rat would appear to be at 
greater risk of irreversible thymic injury from DOTC than 
the weanling rat.
4.2.4 Effect of DOTC in the Diet during Pregnancy on 
Mothers and their Offspring 
The effect of DOTC on pregnant rats |was;a reduction in 
thymic weight of the DOTC-treated mothers with no apparent 
effect on the pups other than a slight reduction in the 
average litte r size. No evidence for DOTC affecting the 
thymus of foetal rats when administered in the diet to the 
mother could be found. However, there- was evidence of thymic 
atrophy in the mothers. CTables 4.8 and 4.9].
4.3 DISCUSSION OF RESULTS
A comparison of weight gains and relative thymus weights 
of control rats in the first experiment indicates that all 
groups were in a period of growth for the duration of DOTC 
exposure and that the thymuses of the two older groups 
had begun to involute. Examination of the thymus weight 
of the DOTC-treated rats indicates that the effect of DOTC 
was marked,in all age groups regardless of the stage of 
thymic development. This suggests that the effect of DOTC 
is neither a change in the rate of normal thymic involution 
nor is i t  restricted to an actively growing thymus. There
was a statistical correlation between age and OOTC-induced 
thymic weight loss with the youngest rats being affected 
most. However, the younger rats had a greater thymus 
weight in both absolute and relative weight at the start 
of the experiment and in the older rats difficulty was 
experienced in dissecting the thymic remnants free from the 
brown fat. The thymic weights in the older rats are 
therefore possibly slightly overestimated due to this 
difficulty in dissection.
The apparent greater reduction in the weight of the 
thymus of younger rats resulting from DOTC treatment must 
also be considered against the fact that the older rats 
are left with less thymic tissue calculated in terms of both 
absolute and relative weight. Thus, i f  injury were to be 
assessed in terms of weight of remaining thymic tissue, 
the older rats would appear to have undergone greater 
injury. The younger rats did show greater alterations 
in other organ weights as well as weight gain. This could 
either be due to the fact that they were in a period of 
rapid growth and development so that any unpalatability of 
diet would have had a greater effect, or alternatively 
because the endocrine control of development was under 
stress due to passible DOTC induced changes in the endocrine 
network. The possibility of DOTC acting via the endocrine 
network could be tested by measuring the levels of the 
endocrine hormones in DOTC-treated rats as compared to 
age-matched control rats or by comparing the effect of DOTC 
on hypophysectomised and intact rats.
The Packed Cell Volume [PCV] and Red Blood Cell [BBC]
measurements indicated that DOTC had no effect upon either 
of these parameters. This supports the earlier finding 
that DOTC does not appear to affect the bone marrow and 
emphasises that any action DOTC has upon T cell maturation 
is at a stage after the divergence of lymphopoiesis from 
erythropoiesis.
The experiment investigating the reversibility of DOTC 
induced thymic weight loss indicated that the recovery was 
limited in both time and extent. The temporal limitation 
indicated that the age of the rat at cessation of treatment 
could affect the reversibility. The quantitative limitation 
seems to indicate that DOTC pretreatment induced premature 
thymic involution similar to that due to aging. I f  there 
were premature thymic involution after DOTC treatment one 
might predict the premature appearance of immune defects 
associated with old age such as decreased antibody production, 
increased incidence of autoantibodies and neoplasias and 
decreased resistance to infections.
The effect of age upon reversibility of DOTC-induced 
injury is partially answered by the experiment which was 
investigating the effect of age upon reversibility. The 
weanling rats demonstrated complete recovery by 4 weeks 
post cessation of DOTC treatment whereas the 6 and 8 week 
old rats at commencement of treatment demonstrated only a 
partial recovery. The weanling rats were again most 
vulnerable to disruption in growth rate and disturbances 
in other organ weights and despite their recovery of thymic 
weight s t il l demonstrated a decreased blood leucocyte 
count. This provides evidence to suggest that the critical
point for reversibi l i  ty of the effects of DOTC treatment 
appears to be the age at cessation of treatment, but 
further experiments involving variable lengths of exposure 
to different ages of rat at onset of treatment would be 
necessary to confirm this. I f  a weanling rat given DOTC 
for 7 weeks demonstrated the same incomplete recovery as the 
6 week old rat given 4 weeks DOTC treatment or an 8 week old 
rat given 2 weeks DOTC, then age at cessation of treatment 
would be the critical factor in reversibility of DOTC 
treatment.
The ijn utero study demonstrated that there was no 
detected risk of thymic injury to the foetus when pregnant 
rats were fed diet containing DOTC. There was no neutrali­
sation of the harmful effects of DOTC upon the thymus by 
pregnancy as the mothers demonstrated thymic atrophy. I t  
would appear that DOTC or whatever active factor i t  produces 
cannot cross the placenta nor be secreted in the milk, as 
exposure of the lactating dams was equally ineffective 
on the suckling offspring. The only effect seen was a 
non-statistically significant drop in litte r size which 
could have been due to maternal malnutrition consequent on 
the unpalatability of the diet.
The hypothesis that DOTC is not transferred across 
the placenta or into mammary secretions could be tested 
by injecting radiolabelled DOTC intravenously and carrying 
out whole body autoradiography. I t  would be necessary to 
inject intravenously rather than gavage as preliminary 
experiments at BIBRA and those of Hennighausen and Lange 
[1979] have shown that absorption from the gastrointestinal
tract is poor and thus the analysis would be obscured by 
the large amounts of radioactivity remaining in the 
gastrointestinal tract. The effects of preweanling 
exposure would also be expected [from the result of the 
effect of age on reversibility experiment] to be completely 
and rapidly reversed upon cessation of treatment at weaning. 
I t  is the mothers rather than the offspring which are at 
greater risk during pregnancy.
In summary although DOTC appears to have greater 
effects when given to young rats, the critical point for 
reversibility of these effects appears to be the age at 
cessation of exposure to DOTC and is less dependent upon 
duration of exposure. This is particularly relevant to 
in utero exposure where the mothers are at greater risk 
of thymic injury than the foetuses. I t  would appear that 
this is a chemical which places the mature rat at greater 
risk than the developing rat.
CHAPTER FIVE
ELECTRON MICROSCOPE STUDIES
5.1 MATERIALS AND METHODS
Animal treatment was as detailed in Section 2.2.
5.1.1 Adrenalectomy
after and
On arrival^ weighing^  randomization the animals
were anaesthetized with pentobarbitone [0.5 mg/100 g body 
weight] and the adrenals removed from two dorsal incisions 
The peritoneum was sewn up using sutures and the skin 
incision closed with Michelle clips which were removed 7 
days later. Post-operatively rats were given 0.9% saline 
in water to drink for the rest of experiment. After 7 day 
the test rats were placed on diet containing 150 ppm DOTC.
5.1.2 Hydrocortisone
The rats were injected intramuscularly with 1.5 mg in 
0.1 ml hydrocortisone [Sigma] daily for 7 days.
5.1.3 Preparation of Sections for Electron Microscopy 
Thymuses for electron microscope examination were
obtained from rats anaesthetised with pentobarbitone [6 mg 
per 100 g body weight]. Whilst under deep anaesthesia a 
cannula was inserted into the aortic arch and each rat 
perfused with normal saline [0.9% NaCl w/v] followed by 4% 
glutaraldehyde in 0.1 M cacodylate buffer [pH 7.2].
The thymus was removed and post Fixed in 1% osmium 
tetroxide, dehydrated in ethanol and embedded in 1:1 
mixture of Agar 100:Araldite epoxy resin. Large area 
sections 1 j^m thick were cut on a Reichart-Turp "Autocut” 
microtome and stained using 1% Toluidine blue. Selected 
areas were then cut at 90 nm thickness on a LKB ultra­
microtome, stained with uranyl acetate and lead citrate 
and examined and photographed on a JEOL JEM 100 x CX 
transmission electron microscope [Glauert, 1974].
5.2 RESULTS
5.2.1 Control Rats
At the light microscope level, thymuses From normal rats 
showed normal morphology with a distinct corticomedullary 
border. At the ultrastructural level the thymocytes were 
characterised by normal nuclei and dense heterochromatin. 
There was lit t le  cytoplasm and Few mitochondria. The 
reticular epithelial cells [REC] exhibited slender cyto­
plasmic processes and large pale nuclei. The abundant 
cytoplasm contained tonofilaments and some rough endoplasmic 
reticulum and mitochondria. Small numbers of electron dense 
granules were also observed in the cytoplasm as well as 
occasional multivesicular bodies. Few macrophages were
present in the cortical area. Fig. 5.1
5.2.2 DOTC-treated Rats
At the light microscope level, thymuses From rats Fed 
□OTC-containing diets For two weeks showed a partial loss 
oF cortical thymocytes and indistinct cortico-medullary 
junctions. AFter 2 weeks exposure to DOTC, a number oF 
vacuolated REC were observed as well as normal-appearing 
REC. A Few macrophages were present and a very Few 
pyknotic thymocytes. At the ultrastructural level, the 
vacuolated REC showed an increase in both nuclear and 
cytoplasmic density with vesiculation oF the rough 
endoplasmic reticulum and an accumulation oF intracellular 
vacuoles, some oF which contained amorphous material. Many 
oF the normal appearing REC showed an increase in the number 
oF secretory droplets present in the distal cytoplasm. The 
majority oF the remaining thymocytes appeared normal.
As the length oF exposure to DOTC-pontaining diets 
was increased there was an increasing loss oF cortical 
thymocytes. IdentiFication oF the cortico-medullary junction 
was not possible aFter longer exposures and the number oF 
vacuolated REC increased. AFter 4 weeks* exposure to 
□OTC-containing diet the many vacuolated REC were easily 
apparent due to the reduction in thymocytes. AFter return 
to normal diets, there was considerable repopulation oF the 
thymus, but some hypocellular areas persisted as did 
numerous vacuolated REC.
5.2.3 Adrenalectomized Rats
Both at the light and the electron microscope levels the
thymuses of adrenalectomized rats exhibited normal 
morphology. The REC cells were normal with a small number 
of open vacuoles containing flocculent particles and 
strands. Granules containing secretory material were 
present in distal areas of the cytoplasm.
5.2.4 Adrenalectomized and DOTC-treated Rats
The morphological changes following DOTC treatment 
post adrenalectomy were the same as those seen in intact 
DOTC-treated animals. The extent of vacuolation in the REC 
and of thymocyte depletion was as marked as in intact 
animals, few thymocytes were seen and these were of the 
medium to large type. The REC showed a considerable increase 
in cytoplasmic vacuolation and very dense staining cells 
were present. The majority of the normal-looking REC
showed an increased frequency of secretory droplets in
\   " ’ *
their distal cytoplasm. \ fig, S.2 .
\
\   .. . \
5.2.5 Hydrocortisone-treated Rats
Rats treated with hydrocortisone showed severe 
depletion of the cortical thymocytes and loss of the 
cortico-medullary junction. The REC exhibited a moderate 
alteration in distribution and morphology, but there was a 
large number of macrophages present which contained large 
amounts of lipid within secondary lysosomes. This would 
appear to suggest that the degenerating thymocytes are 
rapidly removed by phagocytosing macrophages and at the
dose of hydrocortisone used, lit t le  damage was done to the
i ' ' ” " ” 1
i . !
REC . If ig. 5.3 j
5.3 DISCUSSION
The development of the full T-cell-dependent immuno- 
competence appears to have two prerequisites, thymic 
humoral factors [Bach and Papiernik, 1981; Trainin _et al.
1983] and an intimate contact between T-cell precursors 
and the reticulo-epithelial microenvironment [Stutman,
1978]o These studies indicate that DOTC is damaging the 
reticulo-epithelial cells and this is causing some loss 
of immunocompetence. The thymus is s t ill necessary in 
adult life  as is shown by the studies of Taylor [1965] and 
Miller, ( 1952].
After a lapse period, possibly while short-lived 
regulatory T cells live out their normal life span, adult 
thymectomy does impair the immune response. This can be 
measured by the ability to produce antibodies to novel
antigens of T-dependent type or_qraft Versus host .for instance
I treatmenti _
[Taylor, 1 985] . This DOTC ' ,A may j cause a less dramatic
short-term injury to the immune system than hydrocortisone but
the lack of recovery of thymic REC may be an indication
that the damage is more permanent or long-term than that
induced by corticosterones [Fauci , 1975], The actual
effect of this injury to REC upon the production of thymic
humoral factors would be an interesting topic for further
study. This would answer the question, whether DOTC acts
by affecting the levels of humoral thymic factors: the
accumulation of secretory granules in the distal cytoplasm
of treated REC cells and vacuolation indicates that this
may be the case.
Light micrograph of thymic cortex  from control rat  
demonstrating non-vacuola ted  REC and many thymocytes  
1um section stained with Toluidine blue (x 1 6 0 )
f i  g . 5 .1
8 .  *  , ,  ' -  a ,  *  ■
m  I t , ®  ^  "  ■
i ” - '  a  
■ ,  V  '  *  *  V .
’*> 3% f .  * ^  *>  1  
*
, .  O  £  *  ■ •  O' ,  0
»  .  «
.  W ' *  »
l
, T- X '_' ^
a  ?
o '
V  . *
-  y  ( . '  e / ' i i
^ . ; V , y  
v  -
•  i
n \  v  : , >  • >  
(•' i  i .  *
•: 5 *  V » '
J 5 U '  %
f 1
\ ( * v ^ H  $
.  « b  •
• /
( ? )  # »  J  .  ^
U V  *  ■ . 
*  n  •  $
1# 
_ «
A t  f *  r '
•
o  r  ^  v* a *’  **
*  * - 0  • V  «
' • V  1 .  • 4 *  .S k  »
•  • < •  y
r f ?  ©  9  ~
v > i » \ •  •  4 • ’ 'j D •J .  * ♦  ' . *  ♦ i  i V
.  0  f l E S *  *  * 
&  ' i  v  ' . ! » .  •
i 1 '  % ^  ■#
■ f t  v -  i v *  *. ♦ , - >  ■, . 
,  *  J  '  O ' <
*  K '  N*V 4  ♦ c .  V
• e  °  *
o
^  t V  * . ; • / # • •  • »  \  ■»
*
% ‘
%  ^  |
9 •  %* t _  i  * ( >N  »  ~  v v ^<
/•
4
v ®  %  . • '  - ; * ' V V> . v ,  V v < ' ’ *
,  A *  \  ^ " t v • S  •  - i °  ;
/ a M 8 9  X  a 9 _ — '  V -N _ '  A  9  *. y  ^  ^
Light micrograph of thymic cortex from adrenalectomised  
rat fed diet containing 75ppm DOTC for 2 weeks,  
demonstrating vacuolated REC and depletion of thymocytes  
1um section,stained with Toluidine blue (x1 60 )
Fig. 5.3
* •%
-V-<
V  ____* A# »#;
Light micrograph of thymic cortex from rat given 
1.5mg hydrocortisone i.m. daily for 7 days, 
demonstrating atrophic cortex and many macrophages  
1um section stained with Toluidine blue (x1 60 )
CHAPTER SIX
DISCUSSION
6.1 INTRODUCTION
The aim of this study was to investigate the effects 
and the consequences of Di-n-octyl tin dichloride [DOTC] 
in the diet upon the PVG rat. The study was restricted to 
a particular inbred strain of rat in order to direct 
maximum effort towards the exploration of the nature of 
the injury produced by DOTC rather than inter- and intra­
species differences. An inbred strain was selected to 
reduce variation due to genetic factors. The reversibility 
of DOTC-induced thymic injury and factors affecting the 
extent and reversibility were examined. Experiments were 
also undertaken to gain insight into the mode of action of 
□□TC-induced thymic injury, and the consequences upon the 
immune system. The PVG strain was selected as i t  had been 
in routine use in the Immunotoxicology Department at BIBRA 
for studies relating to immune parameters and vitro 
immunological assays.
6.2 KINETICS DF THYMIC REDUCTION IN WEIGHT
In the present studies lit t le  difference was observed 
in the rate of thymic weight loss between animals given 
single or multiple doses of DOTC [100 mg/kg] by gavage and 
animals receiving 75 ppm in the diet [= 2^r 10 mg/kg/day] 
[Figs. 2.1, 2.2 and 2.3]. These findings suggest that the 
rate of thymic weight loss was the maximum attainable by
oral dosing and exceeded the upper limit of a dose-dependent 
response. The results obtained by the different protocols 
may therefore be considered comparable. The lack of dose 
dependency further suggests that the pathways of absorption 
anc/or metabolic activation were saturated at the dose levels 
used.
The results of preliminary autoradiography experiments 
[unpublished observations] indicated that only a small 
percentage of the orally administered dose was absorbed from 
the gastrointestinal tract and this fact is supported by 
metabolic studies by other groups [Seidler et al., 1971].
The alternative hypothesis that DOTC is not absorbed, but 
is metabolised in the gut to an absorbable compound, does 
not appear to be the case since the effects of parenterally 
[ intravenous or intramuscular] administered DOTC were similar 
to those seen after oral administration [Hennighausen and 
Lange, 1979], In the latter experiments much lower dose 
levels were used to produce similar thymic weight loss, 
providing further evidence that DOTC is poorly absorbed 
from the gastrointestinal tract.
A number of possible mechanisms could account for the 
delayed response in relation to thymic weight loss after 
administration of DOTC in the diet or by gavage:
a] delay in absorption and attainment of toxic concen­
trations in thymic tissue;
b] slow conversion of DOTC to a toxic metabolite in 
the tissues;
c] primary toxic injury of an endocrine organ influencing the 
thymus with consequent secondary effects upon the thymus;
d] early sub-cellular injury to thymic tissue resulting
in delayed effects upon the thymus.
Retarded absorption does not appear to be the sole 
cause of the delayed response since autoradiographic 
studies indicated that maximum tissue levels were attained 
after approximately 24 hours [unpublished observations]. 
Furthermore, in studies in which DOTC was administered to 
mice intramuscularly, a delay was also observed befoe 
thymic weight loss was discernable [Hennighausen and 
Lange, 1979] .
There is lit t le  evidence to indicate whether or not 
DOTC requires metabolic activation, nor whether accumulation 
of a toxic metabolite is a prerequisite for thymic injury. 
Further metabolic and pharmacokinetic studies are therefore 
required to clarify whether such a mechanism is implicated 
in the delayed injury.
The present work does not provide any support for 
the hypothesis that thymic loss was a secondary consequence 
of hormonal imbalance induced by DOTC. The fact that 
results obtained in adrenalectomised animals [Chapter 5] 
were essentially similar to those obtained in intact 
animals would appear to exclude the effects of DOTC being 
due to corticosteroids. Furthermore DOTC did not cause 
rapid and gross effects upon the testes [Chapter 2], nor 
on the growth rate, which again suggests that the thymic 
weight loss was not a secondary consequence of the effects 
of sex or growth hormones. In addition, the hormonal 
changes associated with pregnancy did not substantially 
affect the course of events in the dam [Chapter 4].
However, the rat might not be the best species in which to 
examine the combination of DOTC and pregnancy upon the 
thymus as the rat shows much less thymic involution 
during pregnancy than mouse or man [Bauminger and Peleg, 
1978; Maroni and de Soussa, 1973; Nelson _et al., 1967].
In order to elucidate these observations, further work 
might be undertaken using orchidectomised and/or hypo- 
physectomised rats and mice.
In view of the above, i t  seems quite possible that the 
delayed thymic weight loss may result from early 
sub-cellular injury to thymic tissue and delayed effects 
on thymic function. In the present work, electron micro­
scopic studies were limited to observation 14 days after 
dosing [Chapter 5] and there might be some advantage in 
extending these studies to investigate the time course of 
sub-cellular changes taking place in the first few days 
after dosing.
6.3 ORGAN 5PECIFIC EFFECT5 OF DOTC
In these studies i t  was observed that the morphological 
alterations induced by DOTC were limited anatomically to 
the thymus. I t  appeared that the thymus was the primary 
site of toxic effect and such changes as were observed 
elsewhere were secondary to this DOTC-induced thymic injury. 
For example, the preferential loss of W3/25 phenotype T 
lymphocytes in the circulation was of delayed onset and of 
limited extent [Chapters 2 ane 3] such as would have been 
seen after adult thymectomy [Taylor, 1965].
The preferential loss of T lymphocytes after DOTC 
treatment found in the blood was not accompanied by any
diminution in the lymphocyte content of secondary lymphoid 
organs as assessed by morphology at light microscope level 
[Chapter 2] or yield of lymphoid cell suspensions prepared 
From such organs. However, a drop in yield of lymphocyte 
cell populations prepared From blood obtained From DOTC 
treated as compared to control animals was noted [in samples 
prepared For the experiments described in Chapter 3].
There was no decrease in viability in any lymphoid cell 
populations obtained from blood, spleen or lymph nodes in 
treated animals. These findings when combined with the 
absence of any macrophage infiltration into DOTC-treated 
thymuses indicate that DOTC does not appear to be causing 
any lymphocytotoxicity, such as is seen after administration 
of corticosteroids [Chapter 5, and Lundin and Schelin, 1969]. 
This would appear to indicate that the loss of lymphocytes 
could be caused by a lack of replacement of cells lost by 
natural aging rather than any lymphocytotoxic effects.
Future work in which lymphocyte numbers, subsets and
distribution in blood and in the secondary lymphoid organs
were monitored after longer exposure to DOTC might indicate
whether this diminution of W3/25 phenotypic lymphocytes
was restricted to the circulating cells or whether other
lymphoid tissues were affected at a later stage. Further-
51more, i f  the homing of Cr radiolabelled lymphocytes from 
syngeneic recipients was monitored in DOTC-treated rats 
and compared with the homing of control rats, i t  would 
demonstrate i f  there was any redistribution of lymphocyte 
populations such as would occur as a consequence of treatment 
as has been reported after administration of corticosteroids
[Fauci, 1975].
Exposure of pregnant and lactating rats to DOTC in 
the diet did not produce thymic weight reductions in 
the resulting offspring. I t  appeared that DOTC did not 
cross the placenta nor was i t  excreted in the milk. The 
finding of Sienen et _al. , [ 19^7~D "that gavage of suckling
rats with DOTC caused thymic weight loss supports the 
postulate that DOTC was unable to reach foetal and suckling 
rats. Administration of radiolabelled DOTC in future 
studies to pregnant and lactating rats and examination 
of the foetuses and milk for radiolabel would indicate 
whether this postulate was true or not.
6.4 AGE-RELATED EFFECTS OF DOTC
Younger rats were observed to have lost a greater 
absolute and percentage of thymic weight than older rats, 
but older rats were left with less thymic remnant after 
DOTC treatment. I t  is possible that after long term 
exposure to DOTC, rats which commenced treatment at an 
earlier age could run a greater risk of developing the 
defects associated with adult thymectomy than those rats 
whose treatment began at a later stage of development.
The younger rats will have had a larger part of their life  
span without benefit of a functional thymus and its 
regulatory factors, although the consequences of this 
upon the immune system remain unclear.
The effect of age upon recovery was more clear cut.
The younger rats demonstrated complete recovery of thymic 
weight within 4 weeks of return to conventional diet as
compared to age matched controls, whereas the older rats 
demonstrated long term effects of DOTC upon the thymus 
after the cessation of exposure which mimicked premature 
thymic involution. Among the unanswered questions are, 
whether the state ofthymic involution or age is the 
limiting factor to the reversibility of DOTC-induced 
thymic weight loss. I t  is unknown also whether such 
"’premature thymic involution” caused by DOTC administration 
to older rats is likely to be associated with a premature 
appearance of the defects in immunity associated with sene­
scence and thymic involution.
Future work to answer these questions should include 
experiments in which length of exposure and age at start 
of exposure were varied and the reversibility of DOTC-induced 
thymic weight loss monitored.
To separate the effect of age from thymic involution 
i t  would be necessary to find a treatment such as dietary 
restriction CWeindruch _et al_. , 1979], orchidectomy [Castro,
1976] or genetic defects such as seen in hypopituitary 
5nell-Bragg mice [Piantanelli and Fabris, 1978] which 
altered the age at onset of thymic involution. Having 
ascertained that such treatment or conditions did not 
change the effect of DOTC upon the thymus i t  would be possible 
to assess whether the state of thymic involution altered 
the reversibility of the effect of DOTC upon the thymus. 
Insight into the role of the pituitary could be gained by 
either hypophysectomy or the use of genetically hypo- 
pituitary mice [Piantanelli and Fabris, 1978].
6.5 ASSESSMENT OF THYMIC INJURY
In many of the present studies thymic injury induced 
by DOTC was quantified in terms of weight loss of this 
organ [Chapters 2 and 4]. This appears to be a criterion 
of thymic injury as i t  was accompanied by morphological 
changes [Chapters 2 and 5] indicative of damage. There 
was also a decline in T lymphocytes in the blood 
[Chapters 2 and 3] such as would be expected in an animal 
without a functioning thymus. However, no direct attempt 
at quantifying thymic function in terms of production of 
humoral factors and maturation of T lymphocytes was attempted.
Further work to analyse the consequences of DOTC 
induced injury could monitor the production of such thymic 
humoral factors after in vi vo or in vi tro exposure to DOTC.
An, alternative approach could be to monitor the ability of 
the thymus to induce maturation of prorthymocytes by 
implanting DOTC treated thymuses into neonatally thymectomised 
or nude rats. Another method could be to monitor the 
ability of rat^ to recover from sublethal irradiation after 
exposure to DOTC.
6.5 INVESTIGATIONS INTO THE EFFECT OF DOTC UPON THE
IMMUNE SYSTEM
A part of this study was designed to investigate i f  
the effects of DOTC upon the thymus were accompanied by 
any alterations to the immune system. A number of assays of 
immune responses were performed to assess the effects of 
DDTC upon the immunocompetence and to monitor any possible 
alterations in immune balance [Chapter 3].
The preferential loss of lymphocytes observed after 
□OTC treatment was demonstrated to relate mainly to a 
decrease in one particular lymphocyte subpopulation [3.3.2], 
The use of monoclonal antibodies and immunofluorescent 
techniques demonstrated a decrease in lymphocytes expressing 
the W3/25 phenotype compared to lymphocytes expressing the 
0X8 phenotype after treatment with DOTC.
The available monoclonal antibodies only permitted 
identification of two broadly defined subsets of T lympho­
cytes in this study so it  was not possible to detect effects 
upon any particular functional T lymphocyte subset. However 
future work oould be directed to using functional assays of 
helper and suppressor function to assess the effect of 
DOTC upon such functions and subsets. A loss of such 
regulatory functions could have drastic effects upon the 
immune system by either allowing inappropriate immune 
responses such as are seen in allergy and autoimmune 
diseases, or depressing necessary immune responses such as 
are required to resist infections with bacteria, viruses and 
fungi. Disturbances in helper:suppressor T lymphocyte 
subsets such as were described in this study [Chapter 3] 
were also seen by other workers in Aquired Immunodeficiency 
Syndrome [Wallace j3t al.. , 1982] and after chronic and acute
drug-induced immunosuppression [Dupont et a l., 1982].
The W3/25 phenotype lymphocytes have been shown by White 
et al. [1978] to be responsible for allogeneic responses as 
well as helper T cell responses and assays for allogeneic 
responsiveness in this study were examined after treatment
with DOTC.
The in vitro Mixed Lymphocyte Reaction [MLR] used in 
these studies showed a statistically significant depression 
of allogeneic responsiveness whereas the ijn vivo Graft 
versus Host [GvH] demonstrated only a minimal decline in 
allogeneic responsiveness [Chapter 3.3.3]. Allogeneic 
responses are a measure of cell-mediated immunity which is 
vital for defence against viral, intracellular, bacterial, 
fungal infections and according to some workers for 
resistance to neoplasia. Even i f  this decrease in allogenei 
responsiveness is restricted to the blood lymphocytes, i t  
could have deleterious results on the availability of 
competent lymphocytes to resist infections at sites remote 
from secondary lymphoid tissues.
The discrepancy between these two assays [MLR and 
GvH] could, however, have been due to differences in 
sensitivity of the different assays and/or the source of 
lymphoid tissue from which the lymphocytes used in the 
different assays were obtained.
The GvH assay was carried out using lymphocytes 
obtained from the mesenteric lymph nodes, whereas the MLR 
was performed on lymphocytes obtained from the blood. A 
preferential decrease in W3/25 phenotype lymphocytes had 
already been demonstrated in the blood, whereas no 
depletion of lymphocytes was noted in the secondary lymphoid 
organs, and this may in part account for the discrepancy 
between the results of the two assays.
Repetition of the two assays [GvH and MLR] using 
lymphocytes obtained from other sources in future studies
would determine whether this decrease in allogeneic 
responsiveness was restricted to the blood lymphocytes 
after DOTC treatment, or was a measure of the sensitivity 
of the respective assays.
The Ln vivo assay . of cellular immunity based on the 
blastogenic proliferation induced by Phytohaemagglutinin 
CPHA] in this study also exhibited a depression after oral 
exposure to DOTC [3.3.5], This test is often in use as a 
measure of the immunocompetence of lymphocyte populations. 
Cell populations obtained from blood demonstrated a greater 
loss of mitogenic response to PHA after DOTC treatment 
compared to cell populations obtained from either spleen 
or lymph nodes. This depression in mitogenic responsive­
ness was noted in cultures which had been adjusted to a 
constant cell density, not allowing for the decreased 
numbers of lymphocytes observed in the.blood of DOTC treated 
animals. Therefore there is not only a decrease in lympho­
cyte numbers in the blood but also of the ability of the 
remaining lymphocytes to respond to mitogenic stimulation.
The decrease in blastogenic response, as measured by 
response to PHA, however, was not at the reduced levels 
[compared to normal animals] as described by other workers 
in nude rodents [Kindred, 1981; Brooks ^t si., 1980] and 
patients undergoing immunosuppressive therapy [Shih et al., 
1983]. The results obtained therefore are not indicative of 
immunosuppression but more a slight depression in responsive­
ness. This correlates well with the fact that no depression 
in the antibody response, to the T dependent antigen sheep red 
blood cells [SRBC], was demonstrated! .
The results of the assays of immune response discussed 
so far are more comparable to those effects seen after 
adult thymectomy than those seen after immunosuppression 
[Shih _et jal. , 1983].
Several workers have shown that adult thymectomy leads 
to a decreased ability to cope with infections and an 
increased incidence of autoimmunity and allergic-type 
diseases [Smith et al., 1983; Borel et al., 1980; Claman and
Talmage, 1963; Ahmed and Penhale, 1982], Future work 
therefore could be directed towards assessing the ability 
of rats to maintain immune regulation after long-term 
exposure to COTC^ by measuring the ability to resist in­
fections and the production of autoantibodies or hyper­
sensitivity reactions. Rats exhibiting incomplete 
recovery after return to conventional diet from DOTC 
containing diets could also be monitored for any premature 
incidence of the immune defects associated with old age, 
such as increased incidence of autoantibodies and infections 
[Goidl _et si. , 197G; Hallgren _et _al . , 1973; Gerber &t al . ,
1974]. The work of Miller [1962] has also demonstrated 
that adult thymectomised rodents have a decreased ability 
to recover from sub-lethal irradiation. The effect of 
DOTC exposure upon recovery from such immune insult has not 
yet been studied by any worker in this field.
The haematological studies [2.1] and the response 
to PHA [3.3] indicated that the effect of DOTC upon the 
lymphocytes was gradual in both onset and reversibility.
Even after 8 weeks of post-DOTC-treatment recovery, the 
lymphocyte numbers in the blood, thymic weight and
PHA-induced blastogenic response were not restored to the 
same level as age-matched controls. The delayed recovery 
after cessation of DOTC treatment indicates that DOTC has 
subtle effects upon the immune response which persist for 
a considerable period of time after cessation of exposure.
In summary these studies have demonstrated a slight 
but persistent depression of some immune parameters after 
treatment with DOTC as well as a possible alteration in the 
ratio of helper to suppressor T lymphocytes in the blood. 
These findings raise many questions about the long-term 
effects of compounds such as DOTC which cause thymic damage. 
Df particular interest is the finding that the mature rather 
than the young are more vulnerable to long-term deleterious 
consequences from such compounds.
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Sequential Effects of Dioctyltin Dichloride on the Rat Thymus
Klara Miller, Mary P. Scott, and J. R. Foster
The British Industrial Biological Research Association,
Woodmansterne Road, Carshalton, Surrey SM5 4DS, Great Britain
Abstract. Dioctyltin dichloride (DOTC) was administered in the diet at 
150 ppm to male inbred PVG rats over 2 or 4 weeks, followed by 4 weeks on 
normal diet. A marked reduction of thymic weight occurred (p <  0.001) and 
thymic weight remained reduced after reversion to normal diet. White blood 
counts were significantly decreased after 4 weeks treatment and remained 
reduced after 4 weeks recovery. In vitro lymphocyte proliferative assays 
demonstrated reduced mitogen-induced responses both after feeding (60%) 
and return to normal diet (52%) compared to untreated groups. Damage to 
reticular epithelium cells in the thymus, as well as lymphocyte depletion, was 
evident after 2 weeks treatment suggesting that DOTC can effect thymocyte 
maturation via thymic humoral factors.
Key words: Dioctyltin dichloride — Thymus — Lymphocyte Depletion — 
Lymphocyte transformation — Macrophages — Epithelium
Several recent publications (Vos 1977; Faith et al. 1980) have described adverse 
effects of dialkyltin compounds on the thymus. Seinen and Willems (1976) 
demonstrated thymic atrophy in weanling rats after exposure to diets containing 
50 and 150 ppm dioctyltin dichloride (DOTC) followed by recovery after 
cessation of diet. Subsequent reports (Seinen et al. 1979) have been concerned 
with the role of DOTC as an immunosuppressive agent. The present study was 
undertaken to monitor the induction and reversibility of thymic involution 
caused by DOTC and to investigate alterations of immunological parameters 
and thymic ultrastructure. DOTC was administered in the diet at 150 ppm to 
groups of male inbred PVG rats (5 -6  weeks old). The diet was administered 
over 2 or 4 weeks respectively, followed by 4 weeks on a normal diet.
In all treated groups thymic weight was markedly reduced (p <  0.001). 
Thymic weight remained reduced after cessation of treatment and reversion to 
normal diets for 4 weeks (Table 1). This was equally true of the sets of animals 
exposed for a period of 2 weeks. In a matched pair study where animals of three
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Table 1. Effect of feeding 150 ppm DOTC on thymus weight and blood lymphocytes
Thymus
(g)
Lymphocyte
count
(1000/cm3)
% Lymphocyte
response
(2.5 pg/ml PHA)
4 Weeks DOTC
Control 0.267 ± 0.07 678 ± 43.8 100
Treated 0.031 ± 0.003 492 ± 23.8 40
4 Weeks DOTC + 4 weeks recovery
Control 0.233 ± 0.07 641 ± 36.8 100
Treated 0.137 ± 0.07 384 ± 21.3 48
Results expressed as mean ± standard error
different ages (4—5, 5—6, 6—7 weeks) were treated for 2 weeks, the greatest 
reduction of thymic weight (76.5%) occurred in the youngest age group.
Fluorescent labelling revealed no clear treatment-related differences with 
respect to the percentage B and T lymphocytes present in the spleen. However, 
proliferative assays on splenic lymphocytes obtained from 2 and 4 week treated 
animals showed some reduction in phytohaemagglutinin (PHA)-induced 
lymphocyte blastogenesis compared with controls. This was particularly evident 
when doses of PHA (0.416 pg/ml) were suboptimal, leading to responses 29% of 
those in untreated animals. Lack of changes in spleen weights between treated 
and untreated groups indicate a functional impairment rather than a quantitative 
alteration, possibly due to removal of thymic-humoral influences over adherent 
suppressor cells present in the normal rat spleen (Bash et al. 1976).
A marked decrease in circulating lymphocytes was found after 4 weeks 
maintenance on the DOTC-containing diet (Table 1) and this decrease 
continued during the 4 week cessation period. Proliferative assays on circulating 
lymphocytes showed reductions in both 2 and 4 week treated animals at the three 
dose levels of PHA used. When doses were optimal (2.5 (ig/ml) proliferation was 
reduced by 25% after 2 weeks feeding and 60% after 4 weeks feeding compared 
to untreated animals. The ability of lymphocytes to respond to in vitro 
stimulation remained reduced after cessation of treatment (Table 1). This effect 
could be due to loss or dilution of PHA-responsive cells or loss of helper cells. 
The first possibility appears most likely in these short term experiments 
particularly as the functional integrity of the pool of long-lived helper cells was 
demonstrated when 4 week treated animals were challenged with sheep red 
blood cells (SRBC), a T cell dependent heterologous antigen. No difference in 
production of specific antibody against SRBC was found between treated and 
untreated groups.
Histological examination of the atrophied thymus demonstrated loss of 
cortical-medullary boundaries, septal thickening and lymphocyte depletion; 2 
weeks treatment showed septal thickening and lymphocyte depletion. Plastic 
sections (after 2 weeks treatment) additionally revealed an increased number of 
macrophages with phagocytosed material, suggesting some destruction and 
uptake of cellular debris. Reticular epithelial cells (REC) known to secrete
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factors involved in thymocyte maturation showed extensive vacuolation which 
progressively involved an increased number of REC.
It appears that the consequences of DOTC feeding result in a lack of 
short-lived regulatory cells, and can be likened to those following adult 
thymectomy (Bach et al. 1971) causing an immunological imbalance rather than 
due to an immunosuppressive effect. To what extent the damaged REC 
observed affect the thymic microenvironment is not clear, nor whether they may 
account for incomplete recovery of the thymus in these experiments.
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Thymic Involution in Rats Given Diets Containing 
Dioctyltin Dichloride
K l a r a  M i l l e r ,  M a r y  P. S c o t t ,  a n d  J. R. F o s t e r
Immunotoxicology and Pathology Departments, The British Industrial Biological Research 
Association, Woodmansterne Road, Carshalton, Surrey SM5 4DS, United Kingdom
Inbred rats fed diets containing 150 ppm dioctyltin dichloride (DOTC) demonstrated 
a progressive reduction in thymic weight. This was accompanied by a decrease in both 
the number of circulating lymphocytes and their ability to respond to mitogenic stimu­
lation. Morphologically the thymuses from treated animals showed a loss of cortical 
thymocytes and a marked vacuolation of the reticular epithelial cells (REC). After return 
to normal diet for 4 weeks vacuolated REC were still present and PHA-induced lym­
phocyte blastogenesis remained low. Adrenalectomy failed to alter the atrophic action 
of DOTC on the thymus and although administration of hydrocortisone alone produced 
thymic atrophy, no damage to the REC was observed. The results show that thymic 
atrophy resulting from DOTC administration differs from that induced by steroids and 
lends support for the hypothesis that DOTC acts selectively on the thymus in such a 
way that the humoral function of the organ may be affected.
INTRODUCTION
There have been a number of recent reports demonstrating that certain indus­
trial chemicals have a selective effect on the thymus (1-3). Particular attention 
has been paid to the dialkyltin compounds which are used as heat and light 
stabilizers in many chlorinated plastics. Dioctyltin derivatives were developed 
specifically for polyvinylchloride (PVC) items intended to come into contact with 
food and include di-n-octyltin isooctylmaleate and di-n-octyltin 5,5,-bisisooctyl- 
mercaptoacetate (4). The mechanism of PVC stabilization is complex, but one 
pathway is attributed to the ability of the carboxylate ligands of the dioctyltin 
compound to exchange with labile chlorine atoms present in the polymer during 
heat processing (5). This exchange is believed to produce dioctyltin dichloride 
(DOTC) and may also occur during subsequent use.
In 1976, Seinen and Williams reported that DOTC caused severe reduction of 
thymic weight in weanling rats after exposure to diets containing 50 or 150 ppm 
of this compound (6). Histologically, the observed thymic changes were described 
as severe depletion of cortical thymocytes, although evidence of thymocyte de­
struction was not observed (7). Subsequent publications by this group have been 
concerned with the role of DOTC as an immunosuppressive agent (8, 9).
As the two main cell populations of the thymus consist of thymocytes and 
reticular epithelial cells, the question arose whether DOTC might also induce 
alterations in the thymus through an effect on the epithelial cells (REC). These 
are generally considered the source of thymic humoral factors involved in T-cell 
maturation and their secretory function has been described by many investigators 
(10-12). It was therefore decided to investigate the ultrastructure of the rat
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thymus during DOTC-induced involution and to relate changes in the thymus 
with the mitogen-induced blastogenesis of circulating blood lymphocytes.
MATERIALS AND METHODS
Animals. Groups of six young (aged 5-6 weeks) inbred male PVG rats were 
exposed to a standard laboratory diet (Spratts LAD No. 2) containing 0 or 150 
ppm dioctyltin dichloride (DOTC; Schering Chemicals Ltd., England) over 2, 3, 
or 4 weeks, respectively, followed by 1, 2, 3, or 4 weeks on a normal diet. Separate 
animals were taken for morphological and functional and organ-weight investi­
gations. In a separate series of experiments animals were adrenalectomized prior 
to being given DOTC-containing diets for 3 weeks, or injected im with 1.5 mg 
hydrocortisone (Sigma Chemical Co., England) in 0.1 ml phosphate-buffered sa­
line 2 weeks after being maintained on the standard diet.
Leucocyte counts. Samples for total and differential leucocyte counts were 
obtained from the retro-orbital plexus.
Lymphocyte studies. Approximately 10 ml of blood was collected from the 
aorta, and lymphomononuclear cells were obtained after purification on Ficoll- 
Hypaque gradients (Pharmacia Fine Chemicals, England). The number of circu­
lating T lymphocytes was determined from the percentage of lymphoid cells la­
beled by a monoclonal antibody (W3/13; Sera-Lab Ltd., England) and identified 
by immunofluorescent techniques. Lymphocyte transformation assays were set 
up as quadruplicate cultures comprising 1 x 106 lymphocytes per milliliter in 0.2 
ml RPMI 1640 containing 5% fetal calf serum (GIBCO, Grand Island, N.Y.; in­
activated 20 min at 56°C) in microtiter plates (Sterilin, England). Phytohemagglu­
tinin (PHA-HA17, Wellcome, England) at a concentration of 5 |xg/ml was added 
and the cultures were incubated at 37°C for 72 hr in a C 02 incubator. Eighteen 
hours before termination of the cultures [3H]thymidine (1 |xCi/well; 5 Ci/ml; Amer- 
sham/Searle, England) was added, cells were collected with a multiple automatic 
sample harvester (Mash II), and the amount of incorporation was determined in 
a Packard 2650 scintillation counter. The results are expressed as disintegrations 
per min (dpm) as follows: dpm = mean dpm of mitogen-stimulated cultures minus 
mean dpm of unstimulated cultures.
Ultrastructural methods. Morphological examination was performed on groups 
of six animals at each designated time point. They were anesthetized with 6 mg 
sodium pentobarbitone/100 g body wt. Under deep anesthesia a cannula was 
inserted into the aortic arch and each animal was perfused with normal saline 
followed by 4% glutaraldehyde in 0.1 M  cacodylate buffer. The thymus was re­
moved, postfixed in 1% osmium tetroxide, dehydrated in ethanol, and embedded 
in a 1:1 mixture of Agar 100:Araldite epoxy resin. Large area sections, 1 |xm 
thick, were cut on a Reichart-Jung “ Autocut” microtome and stained with 1% 
toluidine blue. Selected areas were then cut at 90-nm thicknesses on an LKB III 
ultramicrotome, stained with uranyl acetate and lead citrate, and examined and 
photographed in a JEOL JEM 100 CX transmission electron microscope.
Statistical analysis. Differences between the parameters measured in treated 
and control animals were compared using Student’s t test. The level of signifi­
cance chosen for all studies was P < 0.01.
64 MILLER, SCOTT, AND FOSTER
TABLE 1
E f f e c t  o f  F e e d i n g  D ie t  C o n t a i n in g  150 ppm DOTC o n  R a t  T h y m u s  W e ig h t  a n d  
C ir c u l a t in g  L y m p h o c y t e s
Weeks on 
diet
Absolute 
thymic weight 
(g)
Relative 
thymus weight
(g/100g,
body wt)
Absolute
lymphocyte
count
(1000/cm3)
Mitogen 
response 
to PHA 
(dpm)
4 Control 0.310 ± 0.014 0.143 ± 0.002 679.6 ± 43.8 82145 ± 6204
Test 0.091 ± 0.020 0.047 ± 0.004 495.2 ± 25.7 27571 ± 7481
P value <0.001 <0.001 <0.01 >0.001 <0.01 >0.001
Control 0.233 ± 0.007 0.079 ± 0.010 633.7 ± 37.3 84807 ± 13535
4 on and Test 0.137 ± 0.007 0.050 ± 0.010 382.2 ± 21.5 31235 ± 9025
4 recovery P value <0.001 <0.001 <0.001 <0.001
Note. Results are expressed as means ± SEM for 24 animals.
RESULTS
In all treated groups thymic weight (gram wet weight) was markedly reduced. 
In the animals fed DOTC-containing diets for 4 weeks, retum-to-normal diets 
resulted in increased cellularity of the thymus, although thymic weight remained 
significantly reduced (Table 1). The low thymic weight after treatment was ac­
companied by a decrease in circulating lymphocytes. Surface marker analysis did 
not, however, demonstrate a decrease in the proportion of T cells present (80 and 
77% for control and treated rats, respectively). Viability, as determined by trypan
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Fig. 1. Uptake of [3H]thymidine (mean ± SEM) in response to PHA stimulation of 2 x 105/well 
blood mononuclear cells from rats fed DOTC for 4 weeks (■) compared to control (□) rats.
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blue exclusion, was greater than 95% at all times. The PHA-induced lymphocyte 
blastogenesis was significantly reduced after 4 weeks of DOTC-containing diet 
compared to control animals (Fig. 1) and remained reduced after cessation of 
treatment (Table 1).
Histopathological and Ultrastructural Observations
Control rats. Thymuses from untreated rats showed normal thymic morphology 
and a distinct corticomedullary junction was always apparent at the light micro­
scope level. U ltrastructurally cortical thymocytes were characterised by round 
nuclei, dense heterochrom atin, little cytoplasm, and few mitochondria. The re­
ticular epithelial cells (REC) exhibited slender cytoplasmic processes and large, 
pale nuclei (Fig. 2). The abundant cytoplasm contained tonofilaments and some 
rough endoplasmic reticulum and mitochondria. Small numbers of electron dense 
granules were also observed in the cytoplasm along with occassional multivesic- 
ular bodies. Few macrophages were present in the cortical area.
Adrenalectomized rats. Both at light and electron microscope levels thymuses 
from operated animals exhibited normal morphological features.
DOTC-treated rats. Thymuses from rats fed DOTC-containing diets for 2 weeks
f t t
F ig . 2. Reticular epithelial cell from  control rats showing the presence o f tonafilaments and m ito­
chondria in the cytoplasm ( X6600).
F ig . 3. (a). Reticular epithelial cell from  rats fed DOTC for 2 weeks showing vesiculation o f the 
endoplasmic reticulum and intracellular vacuoles ( x  6600). (b) Cytoplasmic section o f reticular epi­
thelial cell from  rats fed DOTC for 2 weeks showing an accumulation o f secretory droplets ( x 13000).
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showed a partial loss of cortical thymocytes and indistinct corticomedullary junc­
tions. A number of vacuolated REC was observed together with normal appearing 
REC. There were few macrophages present and very few pyknotic thymocytes. 
U ltrastructurally the vacuolated REC showed an increase in both nuclear and 
cytoplasmic densities with vesiculation of the rough endoplasmic reticulum and 
an accumulation of intracellular vacuoles, some containing amorphous material 
(Fig. 3a). Many of the otherwise normal appearing REC showed an increase in 
the number of secretory droplets present in the distal cytoplasm (Fig. 3b). The 
majority of remaining thymocytes had a normal appearance.
With increasing length of exposure to DOTC there was a continued loss of 
cortical thymocytes. Positive identification of the corticomedullary junction was 
not possible and the number of vacuolated REC observed was greatly increased 
(Fig. 4). When the animals were returned to a normal diet a weekly examination 
of the thymuses showed a considerable repopulation with, however, persistance 
of hypocellular areas and of numerous vacuolated epithelial cells.
Adrenalectomized and DOTC-treated rats. Morphological changes following 
oral DOTC treatm ent were as marked in adrenalectomized rats as in nonoperated 
animals.
Hydrocortisone treated rats. Animals treated with hydrocortisone showed se­
vere depletion of cortical thymocytes and loss of the corticomedullary junction. 
No alteration in the appearance and distribution of REC was observed, but mac­
rophages were present in greatly increased numbers (Fig. 5). Ultrastructural ex-
F ig . 4. L ight micrograph o f thym ic cortical area from  rats fed DOTC for 4 weeks showing vacuolated 
cytoplasm o f the reticu lar epithelial cells (x630).
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amination showed that the macrophages contained large lipid droplets within 
secondary lysosomes.
DISCUSSION
Development of the full range of T-lymphocyte functions appears to require 
both thymic humoral factors (13) and an intimate contact between T-cell precur­
sors and the epithelial microenvironment (14). In the present investigation thy­
muses from rats on DOTC diets contained a considerable number of vacuolated 
recticular epithelial cells (REC). Alterations in REC were apparent before thy­
mocyte depletion occurred, suggesting that DOTC may damage the epithelial cells 
rather than thymocytes directly. An increased number of secretory granules in 
normal-appearing REC was also observed, possibly due to inhibition of the se­
cretory activity of the cells (15). This possibility is supported by published ob­
servations that REC of Swiss/Gif mice contain similar granules, described by the 
authors as a nonsecreted form of thymosin (16, 17).
In the present study vacuolated REC were observed in the partially repopulated 
thymus four weeks after DOTC exposure, and the ability of circulating lympho­
cytes to respond to PHA-induced blastogenesis remained lower than in untreated 
controls. This decreased responsiveness did not appear to be due to loss in via­
bility or to a decreased proportion of T lymphocytes. The W3/13 antibody used 
as a surface m arker labeled all thymus-derived cells, however, and subpopulations
F ig . 5. L igh t micrograph o f thym ic cortical area from  rats treated w ith hydrocortisone showing an 
accumulation o f macrophages and normal-appearing reticular epithelial cells (x630).
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of T lymphocytes were not assessed. It is possible that damage to REC produced 
by dietary DOTC causes some thymocytes to enter alternate pathways of differ­
entiation which generate nonfunctional T lymphocytes (18, 19).
Similar effects on thymic REC have been described in studies using antiserum 
to REC and antilymphocyte serum (ALS), and alterations in REC morphology 
were observed prior to depletion of cortical thymocytes (20). In the published 
study damage to REC was accompanied by functional alterations in splenic ro­
sette-forming lymphocytes, providing some support for the decreased blastogenic 
response found in the present investigation. The effects of ALS and DOTC dif­
fered, however, in their dependency on stress-induced release of corticosteroids 
and, whereas adrenalectomy reduced the thymic damage due to ALS in mice 
(20), thymic involution following DOTC treatment was as marked in adrenalec­
tomized rats as in nonoperated animals. Circulating levels of corticosteroids, 
therefore, do not appear to play a part in the action of DOTC on the rat thymus. 
Thymic involution produced by systemically administered hydrocortisone did not 
result in damage to REC in the present experiments, emphasizing that DOTC has 
a different mechanism of action from corticosteroids or antilymphocyte serum.
All the investigations undertaken so far support the hypothesis that DOTC acts 
selectively on the thymus in such a way that the humoral function of the organ 
may be affected. This alteration could lead to inadequate production of subpop­
ulations of T lymphocytes, such as the suppressor or regulatory cells which exert 
fine control over the immune system. Studies are presently in progress to eluci­
date the mechanism by which DOTC or DOTC metabolites affect thymic structure 
and function.
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